| November 15, 2009 (Vol. 29, No. 20) |
|
Pooled Genome-Wide shRNA Screening
Heather Holemon, Ph.D.
Victoria Rusakova
|
|
Transfection Market Clamors for Silver Bullet
Jonathan Witonsky
|
|
NBS Experiences Post-Acquisition Growth
Carol Potera
|
|
Oklahoma Seeks to Retain Local Research
Gail Dutton
|
|
Making the Most of Transfection Processes
Catherine Shaffer
|
|
Head Start Boosts Value of Stability Testing
Vicki Glaser
|
|
"Simplexity" of Flow Cytometry Technology
J.C. Mason, Ph.D.
|
|
Taking Multiplexing to the Next Level
K. John Morrow Jr., Ph.D.
|
|
Strategies for Companies Targeting GPCRs
James Netterwald, Ph.D.
|
|
Flow Cytometry's Expanding Niche
Richard A. Stein, M.D., Ph.D.
|
|
Improving and Enhancing the Use of Quantitative PCR
Kathy Liszewski
|
|
Sidebar: Industry Experts Share Flow Cytometry Insights
|
|
Cracking Down on Misinformation
Bruce F. Mackler, Ph.D., J.D.
|
|
Developments in Focused Kinase Libraries
Richard Hill, Ph.D.
|
|
Analytical Considerations in Formulation
Sian Estdale, Ph.D.
|
|
Dried Blood Spots for Toxicokinetic Studies
James C. Robbins, Ph.D.
Lee Goodwin, Ph.D.
Phillip Turpin, Ph.D.
|
|
| November 1, 2009 (Vol. 29, No. 19) |
|
Cellular-Signaling Pathway Signatures
Wendy Weatherford
Alexander Karasyov, Ph.D.
James Schwaber, Ph.D.
Frauke Rininsland, Ph.D.
|
|
Sparing Patients the Needle Remains a Priority
Bruce Carlson
|
|
Senesco Attempts to Exploit Cell Death
Carol Potera
|
|
Lilly Unveils Green Biotechnology Campus
Vicki Glaser
|
|
Search Intensifies for Diabetes Drugs
Nina Flanagan
|
|
Single-Use Systems Make Headway with Skeptics
Angelo DePalma, Ph.D.
|
|
Sample Prep Advances Extend Mass Spec
K. John Morrow Jr., Ph.D.
|
|
New Capabilities Fortify Biodefense Tools
Gail Dutton
|
|
Animal Imaging Transforms Development
Elizabeth Lipp
|
|
Third Option for Stem Cell Research Emerges
Kenneth C. Aldrich
|
|
Certainty Not Required for Inventorship
William L. Warren
S.Alex Cao, Ph.D.
|
|
Preserving the Integrity of Statistics
Zachary N. Russ
|
|
GEN's GREENbiopharma Conference Focuses on the Economic Rationales of Going Green in Biotech
|
|
Dual Scan Multiple Reaction Monitoring MS
Joanne Mather
Paul D. Rainville
Robert S. Plumb, Ph.D.
|
|
Applying Real-Time PCR to Strain Identification
Arun Apte
|
|
Using ClonePix FL to Assess Monoclonality
Julian F. Burke, Ph.D.
Christopher J. Mann, Ph.D.
Sky Jiang
Kerensa J. Klottrup, Ph.D.
Natalie Smithers, Ph.D.
Omee Ahmed
|
|
Shaken Bioreactors Provide Culture Alternative
Tibor Anderlei, Ph.D.
Christoph Cesana
Cedric Bürki
Maria De Jesus, Ph.D.
Markus Kühner
Florian Wurm
Rene Lohser
|
|
Gains Steadily Building in Biotech Sector
G.Steven Burrill
|
|
| October 15, 2009 (Vol. 29, No. 18) |
|
High-Resolution Melt Analysis Applications
Viresh Patel, Ph.D.
|
|
Firms Seek to Prove Cancer Stem Cell Hypothesis
Keith A. Markey, Ph.D.
|
|
Merrion Strives to Turn IV Drugs into Tablets
Carol Potera
|
|
High-Content Screening Surges Ahead
Vicki Glaser
|
|
Stem Cell Technologies Boost Regenerative Medicine
James Netterwald, Ph.D.
|
|
Enhancement of Cell Culture Techniques
Angelo DePalma, Ph.D.
|
|
Use of Microarrays Increasing Rapidly
Sophia Fox
|
|
qPCR Faces Growing Pains Head-On
Kathy Liszewski
|
|
Novel Tools Streamline Purification Process
K. John Morrow Jr., Ph.D.
|
|
Fighting Pancreatic Cancer's Intractable Nature
Patricia F. Dimond, Ph.D.
|
|
GEN's Cryptogram Challenge Solved
|
|
DTC Genomics & Leading-Edge Ethics
Chris MacDonald, Ph.D.
|
|
Cells That Get No Respect
|
|
Update on Evolving Regulatory Guidance
Bruce F. Mackler, Ph.D., J.D.
|
|
Assessment of Drug Interaction Potential
Igor Mezine, Ph.D.
Chris Bode, Ph.D.
Sid Bhoopathy, Ph.D.
|
|
Automated Cell Culture with 3-D Substrate
Nadia A. Badr
Brad Justice
Robin A. Felder, Ph.D.
|
|
Simulated Moving Bed Chromatography
Anthony Grabski, Ph.D.
Robert Mierendorf, Ph.D.
|
|
| October 1, 2009 (Vol. 29, No. 17) |
|
Studying the S-Glutathionylation of Proteins
Thomas G. Brock, Ph.D.
Micah Doty
|
|
Biosimilar Market Fails to Meet Projections
Bruce Carlson
|
|
Novasep Morphs Into Full-Service Company
Sophia Fox
|
|
Hong Kong Sees Opportunities with TCMs
Robert Yuan, Ph.D.
|
|
Advances in Quantitative Proteomics
Patricia F. Dimond, Ph.D.
|
|
Contract Manufacturing Demand Remains Strong
Cindy Liu
William Downey
|
|
Novel Approaches Simplify Sample Prep
Elizabeth Lipp
|
|
Protein Expression Poised for Reinvention
K. John Morrow Jr., Ph.D.
|
|
Venture Philanthropy Bets on Risky Projects
Jonathan Simons, M.D.
|
|
Laskers Honor Stem Cell & Cancer Research
|
|
New Assays Invigorate Biomarker Discovery
Catherine Shaffer
|
|
Written Descriptions: How Much Is Enough?
Courtenay C. Brinckerhoff
|
|
Economic Realities of Clusters
Michael Sable, Ph.D.
|
|
Optimizing CHO Cell Culture Conditions
Christopher A. Sellick, Ph.D.
Arfa R. Maqsood
Alexandra S. Croxford, Ph.D.
Alan J. Dickson, Ph.D.
Royston Goodacre, Ph.D.
Gill M. Stephens, Ph.D.
|
|
Cell-Counting Technologies Are Evolving
Clare Rogers
Erin Gatza, Ph.D.
|
|
Trials and Tribulations for Melanoma Drugs
Simos Simeonidis, Ph.D.
|
|
| September 15, 2009 (Vol. 29, No. 16) |
|
Live-Cell Luminescent Assays for GPCR Studies
Brock F. Binkowski, Ph.D.
Frank Fan, Ph.D.
Keith V. Wood, Ph.D.
|
|
Tests to Rapidly Diagnose Sepsis Essential
Aruna Rajan
Harry Glorikian
|
|
Symyx Technologies Ventures Into Novel Arena
Carol Potera
|
|
Karolinska Development Spins Off New Group
Sophia Fox
|
|
In Defense of Virtual Development Models
Greg Dombal
Lauren Sherman
|
|
3-D Cell Culture for Discovery & Bioprocess
Nina Flanagan
|
|
HPLC Advances for Biomolecular Analysis
Susan Aldridge, Ph.D.
|
|
Research Reveals the Influence of miRNA
Kathy Liszewski
|
|
Strategies for Successful Formulation
Angelo DePalma, Ph.D.
|
|
Vaccine Production Shifts to High Gear
Vicki Glaser
|
|
Metabolic Profiling Crucial to Unveiling Cellular Complexity
Richard A. Stein, M.D., Ph.D.
|
|
Quebec Eyes Biotech as Key Growth Sector
Vicki Glaser
|
|
3-D Cerebral Cortex Model
|
|
Agency Gains Regulatory Clout
Bruce F. Mackler, Ph.D., J.D.
|
|
Parvovirus B19 VLP Vaccine Manufacturing
Daniel A. Shelly, Ph.D.
Victor Van Cleave, Ph.D.
|
|
Deciphering the Process of Gene Evolution
|
|
Stability Testing for Protein Therapeutics
David Gregson, Ph.D.
Lindsay Cole, Ph.D.
|
|
Reproducible Dispensing of Live Cells
Sini Suomalainen
|
|
| September 1, 2009 (Vol. 29, No. 15) |
|
Sample Enrichment Technology Advances
Clotilde Teiling
Thomas Jarvie, Ph.D.
|
|
Access to Global Populations Speeds Trials
Douglas Peddicord, Ph.D.
|
|
EcoBiotics Scours Rainforest for Compounds
Carol Potera
|
|
Live-Cell Imaging Increases Impact on R&D
Gail Dutton
|
|
Innovation Marks Steady Growth of Asian Biotech
Gail Dutton
|
|
Peptide Therapies Coming Into Their Own
James Netterwald, Ph.D.
|
|
Next-Gen Sequencing Becoming Ubiquitous
Catherine Shaffer
|
|
Next-Gen Presents Array of Opportunities
Elizabeth Lipp
|
|
Streamlining Protein Sample Preparation
K. John Morrow Jr., Ph.D.
|
|
Bioprocess Monitoring Relies on Connectivity
Angelo DePalma, Ph.D.
|
|
Q&A on Sartorius Stedim Biotech/SAFC Deal
|
|
Searching for Appropriate Cancer Biomarkers
Amnon Gonenne, Ph.D.
|
|
Changing the Face of Clinical Medicine
K. John Morrow Jr., Ph.D.
|
|
MDx Hones In On Near-Patient Setting
Nina Flanagan
|
|
Personalized Medicine Realizing Its Promise
Edward Abrahams, Ph.D.
|
|
Timing Rules for Biological Deposits in Flux
Joseph Hsiao
|
|
Activism, Mendacity, and Pathological Science
Henry I. Miller, M.D.
|
|
Cellular Imaging and Analysis Roundtable
|
|
Choosing the Right Model
|
|
Emory University Named to NCI Chemical Biology Consortium
|
|
Simplifying Antibody Conjugation Processes
Nick Gee, Ph.D.
|
|
Demystifying Medicinal Chemistry Efforts
Steve Gardner
|
|
Using Metabolomics to Optimize Bioprocessing
Don Rose, Ph.D.
|
|
Antidotes for an Ailing Biotechnology Sector
Sumantha R. Sedor
|
|
| August 1, 2009 (Vol. 29, No. 14) |
|
Addressing Ligand Binding Assay Deficiencies
Kevin Brady
|
|
Infectious Diseases a Key MDx Market Driver
Kevin Leong
|
|
Novel Alzheimer’s Therapies Gaining Ground
Carol Potera
|
|
GEN Update on Promising Emerging Biotechnologies
|
|
Microarrays for Gene-Expression Studies
Elizabeth Lipp
|
|
PCR Technology Review: Standardization of qPCR and RT-qPCR
Stephen A. Bustin, Ph.D.
Jo Vandesompele, Ph.D.
Michael W. Pfaffl, Ph.D.
|
|
Italian Biotech Revamps Old-World Mindset
Alberto Onetti, Ph.D.
Charles S. Versaggi, Ph.D.
Bruce F. Mackler, Ph.D., J.D.
|
|
Overcoming Phase II Attrition Problem
Allan B. Haberman, Ph.D.
|
|
Making Bioprocess Scale-Up More Robust
Angelo DePalma, Ph.D.
|
|
Bringing Greater Efficiency to Antibody Manufacturing
Susan Aldridge, Ph.D.
|
|
Bioreactor and Fermentor Market Trends
Vicki Glaser
|
|
Perspective on PR: Building an Effective Communication Program
Tony Russo, Ph.D.
|
|
Innovative Drug Screening Methodologies
K. John Morrow Jr., Ph.D.
|
|
Utilizing Biomarkers to Their Full Extent
Nina Flanagan
|
|
Ninth Circuit Rules on IP and Antitrust Issues
Christine Garrett Devlin
William Diaz
|
|
Technological Advances Increase the Risk of Genetic Identity Theft
Alan McHughen, Ph.D.
|
|
Biosimilars and Follow-On Branded Biologics
Bruce F. Mackler, Ph.D., J.D.
|
|
Single-Use Noninvasive Sensing Technology
Jim Furey
|
|
High-Throughput Nanovolume qPCR
David Gelfand, Ph.D.
Kumar Kastury, Ph.D.
|
|
Streamlining In Silico Compound Profiling
François Petitet
|
|
Stabilization Method for Biological Samples
Mats Borén, Ph.D.
|
|
Increasing Production Process Efficiency
Merlind Muecke, Ph.D.
Susanne Leonhartsberger, Ph.D.
|
|
Biotechnology Investments Exhibit Resilience
Robert Dellenbach
|
|
| July 1, 2009 (Vol. 29, No. 13) |
|
Automating Magnetic Bead Multiplex Assays
Jason Greene
|
|
Stem Cell Possibilities Energize the Market
Harold Gross
|
|
Microsoft Strengthens Its Involvement in Life Sciences
Carol Potera
|
|
Building a Successful Biotech Incubator
Gail Dutton
|
|
Upgrading Cell-Based Viability Assays
K. John Morrow Jr., Ph.D.
|
|
Meeting Biomagnetic Separation Needs
Gail Dutton
|
|
Creating Therapies via the RNAi Route
Patricia F. Dimond, Ph.D.
|
|
High-End Mass Spec Systems Introduced
Vicki Glaser
|
|
Competition Mounting in Peptide Market
Vicki Glaser
|
|
European Overview: Firms Look for Niche in Peptide Synthesis
Sophia Fox
|
|
Getting Real with Downstream Processing
Angelo DePalma, Ph.D.
|
|
Applying Novel Biologic Production Methods
Susan Aldridge, Ph.D.
|
|
Getting the Most out of Quantitative PCR
Catherine Shaffer
|
|
Choosing a Clinical Trial Disclosure System
Satish Tadikonda
|
|
Navigating Pharmacogenomics Patenting
Y. Philip Zhang, Ph.D., J.D.
|
|
Therapy and Enhancement: Is There a Moral Difference?
Patrick Lin, Ph.D.
|
|
More from the Floor at ASMS: Boosting Analytical Capabilities
Vicki Glaser
|
|
Automating Physical Passage of Stem Cells
Kristi Hohenstein, Ph.D.
Gary Bright, Ph.D.
Anuradha Soundararajan
|
|
Expanding Disposable Depth-Filter Applications
Scott W. Anderson
Mike Collins
Manfred Muehl
|
|
Fluidics-Free Molecular Interactions Analysis
Krista Witte, Ph.D.
|
|
Significant Change Predicted for Bioindustry
Benjamin J. Conway
|
|
| June 15, 2009 (Vol. 29, No. 12) |
|
Solutions for DNA Copy-Number Analysis
Vanessa L. Ott, Ph.D.
|
|
The Rise of Short- and Rapid-Acting Opioids
Terence McManus, Ph.D.
|
|
Tackling Production Problems with Hydrogels
Carol Potera
|
|
Catching Up to Multiplexing Technology
Elizabeth Lipp
|
|
Protein Engineering Reaches New Frontiers
Nina Flanagan
|
|
Improving Biomarker Validation
Gail Dutton
|
|
Alternative Feedstocks Boost Ethanol Production
Vicki Glaser
|
|
Tech Transfer Key to CMO Cost Reductions
Susan Aldridge, Ph.D.
|
|
Nature and Nurture Benefit Cell Lines
Angelo DePalma, Ph.D.
|
|
Perspective: Boutique-Level Service in the CMO Sector
Roger Lias, Ph.D.
|
|
Banked-Specimen Retrospective Studies
Jeffrey Gibbs
|
|
Spotlight on the FDA
Bruce F. Mackler, Ph.D., J.D.
|
|
Screening Membrane-Associated Targets
Anthony L. Shrout , Ph.D.
|
|
Advancing Western Blots with Digital Imaging
Mike Collier, Ph.D.
Lisa Isailovic
Tamara R. Golden, Ph.D.
|
|
Real Time Multiplexed Protein Measurement
Wei Hu, Ph.D.
Jean-Francois Houle, Ph.D.
Paul Smith
|
|
2-D DIGE Improves Process Understanding
Åsa Hagner-McWhirter, Ph.D.
Maria Winkvist, Ph.D.
Lennart Björkesten, Ph.D.
Gunnar Malmquist, Ph.D.
|
|
| June 1, 2009 (Vol. 29, No. 11) |
|
High-Content Cytotoxicity Analysis
Paul Wylie, Ph.D.
Mike Janes
|
|
Molecular Cytogenetic Tools
Jonathan Witonsky
|
|
Ambit Has High Hopes for Kinase Screening Tool
Carol Potera
|
|
Long-Term Viability in a Down Market
Tamara Zemlo, Ph.D.
|
|
San Diego Pioneers Cleantech Solutions
Carol Potera
|
|
Novel Antibody Microarray Technology
Sophia Fox
|
|
Investigating and Focusing on Ion Channels as Drug Targets
Sue Pearson, Ph.D.
|
|
Epigenetics Fortifies Cancer Armamentarium
Gail Dutton
|
|
Delivery Approaches for RNAi-Based Drugs
James Netterwald, Ph.D.
|
|
Single-Cell Genomics Clarifies Big Picture
Richard A. Stein, M.D., Ph.D.
|
|
Overcoming Protein Production Hurdles
K. John Morrow Jr., Ph.D.
|
|
China Increases Healthcare Investment
Qing Xia
Daming Chen
|
|
Ramping Up Flu Vaccine Efforts
Gail Dutton
|
|
Patentability of Genetic Sequences Limited
William L. Warren
Lei Fang, Ph.D., M.D.
|
|
Science and Technology Are Essential to Economic Recovery
Henry I. Miller, M.D.
|
|
Purdue Scientist Gets Moving on Vaccine against H1N1
|
|
Controlling Nutrient Release in Cell Cultivation
Antje Neubauer, Ph.D.
Russell Golson
Kaisa Ukkonen
Mirja Krause
Hanna Tegel
Jenny Ottosson
Marianne Wittrup Larsen
Karl Hult
Peter Neubauer
Antti Vasala
|
|
Using Mass Spectrometry for Tissue Imaging
Maria C. Prieto Conaway
Shousong Cao
Farukh Durrani
Youcef Rustum
Ping Wang
Khin Marlar
Latif Kazim
|
|
Managing Data from Screening Effectively
Andy Vines
|
|
Identifying New Gene-Expression Patterns
Nicola C. Day, Ph.D.
Sandra Williams, Ph.D.
|
|
Improving Protein Yields in Mammalian Cells
Steven Williams, Ph.D.
Rocky Cranenburgh, Ph.D.
|
|
Defending the Actions of Activist Shareholders
David Sable, M.D.
|
|
| May 15, 2009 (Vol. 29, No. 10) |
|
Managing Protein Biomarker Assay Workflow
Ruth A. VanBogelen, Ph.D.
Richard C. Jones, Ph.D.
M. Walid Qoronfleh, Ph.D.
|
|
Are In Vitro Diagnostics Recession-Proof?
Bruce Carlson
|
|
Forging Isobutanol with Modified Microbes
Carol Potera
|
|
Tough Times Ratchet Up Need for Partners
Susan Aldridge, Ph.D.
|
|
Natural Resources Buoy Chilean Biotech
Robert Yuan, Ph.D.
|
|
New MS Tools Advance Biomolecular Studies
K. John Morrow Jr., Ph.D.
|
|
CGH Sheds Its Light on Disease Etiology
Mary Addonizio
|
|
“Greening” of Labs and Manufacturing
Angelo DePalma, Ph.D.
|
|
Delivery Firms Focus on Efficiency & Efficacy
Patricia F. Dimond, Ph.D.
|
|
Nasal Administration Methods Stake Out Niche
Alan Smith, Ph.D.
|
|
Decoding Cell Communication
Kathy Liszewski
|
|
Strategies for Removing Viruses from Cell Lines
Gail Dutton
|
|
GEN's Spotlight on the FDA
Bruce F. Mackler, Ph.D., J.D.
|
|
Obtaining Reliable PCR from Seed DNA
Les Hoffman, Ph.D.
Shannon Krueger
|
|
High-Speed Sample Volume Measurement
Chris Walsh
|
|
New Tool Recombineers the DNA of E. coli
Tim Zeppenfeld, Ph.D.
|
|
| May 1, 2009 (Vol. 29, No. 9) |
|
Lab Automation Protocols and Virtual Workcells
Alan H. Katz, Ph.D.
|
|
Securing a Slice of NIH Stimulus Funding
Christianne Bird
|
|
PharmAthene Secures Biodefense Position
Carol Potera
|
|
Emerging Biotechnology Clusters
Gail Dutton
|
|
ADMET Increasingly Integral to Discovery
Elizabeth Lipp
|
|
Practical Applications of Systems Biology
Richard A. Stein, M.D., Ph.D.
|
|
Ramping Up Effort for Improving Kinase Assays
Nina Flanagan
|
|
Novel Ways of Looking at Old Problems
K. John Morrow Jr., Ph.D.
|
|
Oligo Market Benefits from RNAi Focus
Vicki Glaser
|
|
HPLC Thrives on Speed and Efficiency
Angelo DePalma, Ph.D.
|
|
Recent Decisions Curtail Personalized Medicine
Brenda Herschbach Jarrell, Ph.D., J.D.
Fangli Chen, Ph.D., J.D.
|
|
Rebuttal: Gov’t Should Not Open Coffers to VC Firms
William Bains
|
|
Arguments against President Obama’s Stem Cell Policies
Gilbert Meilaender, Ph.D.
|
|
Automated Capillary Isoelectric Focusing
|
|
Sugars Are Sweet
|
|
Small and Smaller
|
|
Identifying Cardiotoxic Compounds
Blake D. Anson, Ph.D.
Junyi Ma, M.D., Ph.D.
Jia-Qiang He, Ph.D.
|
|
Standardization in Biomarker Discovery
James R. Dasch, Ph.D.
Keith R. Solomon, Ph.D.
Marina Hincapie, Ph.D.
David Sarracino, Ph.D.
|
|
Improving LC/MS Analysis of Oligonucleotides
Michael McGinley
Gregory Scott
|
|
LIMS Streamlines Translational Science
Trish Meek
|
|
VC Lock-Down Mode Paralyzes Bioindustry
Rod Raynovich
|
|
| April 15, 2009 (Vol. 29, No. 8) |
|
Breaking HTS Cell-Based Assay Bottlenecks
James P. Brady Jr., Ph.D.
Karen A. Donato, Ph.D.
|
|
Synthetic Bio's Promise Places It on Fast Track
Mark Bunger
|
|
Firm Aims to Regulate RNA in Rare Diseases
Ilene Schneider
|
|
Fine-Tuning Sample Preparation Techniques
Elizabeth Lipp
|
|
Budgets Shifting in Biopharma Manufacturing
Eric S. Langer
|
|
POC Testing Predicted to Transform Healthcare
Ian George, Ph.D.
|
|
Capitalizing on Fragment-Based Discovery
Kathy Liszewski
|
|
Focused Assays Lead to More Potent Drugs
Nina Flanagan
|
|
Novel Systems Zero In on the $100 Genome
K. John Morrow Jr., Ph.D.
|
|
Removing Impediments in Downstream Processing
Angelo DePalma, Ph.D.
|
|
Partnerships Strengthen Finland Biotech
Susan Aldridge, Ph.D.
|
|
Spotlight on the FDA
Bruce F. Mackler, Ph.D., J.D.
|
|
Transforming Bioprocessing as We Know It
|
|
Detection Method for Conformational Change
Joshua Salafsky, Ph.D.
|
|
Easing Challenges in QbD Implementation
Andreas Schneider
|
|
Accelerating Preclinical Imaging Workflow
Santosh S. Arcot, Ph.D.
|
|
| April 1, 2009 (Vol. 29, No. 7) |
|
High-Content Methods to Assess Toxicity
Mark A. Collins, Ph.D.
|
|
Cancer Molecular Diagnostics Take the Stage
Sudeep Basu, Ph.D
|
|
Firm on Quest to Improve Biomanufacturing
Carol Potera
|
|
Unveiling Cellular Bioenergetics’ Secrets
Richard A. Stein, M.D., Ph.D.
|
|
Digital Gene-Expression Profiling
Vicki Glaser
|
|
Traditional Strengths Solidify Chilean Biotech Industry
Gail Dutton
|
|
Ongoing Pursuit of Sustainable Operations
Angelo DePalma, Ph.D.
|
|
MDx Will Drive Personalized Medicine
Vicki Glaser
|
|
Unearthing More Effective Therapies for Anthrax
Matthew Meldorf, M.D.
|
|
Getting a Handle on Metabolic Disorders
David Daniels, Ph.D.
|
|
New qPCR Workflows Accelerate Discovery
Lloyd Dunlap
|
|
Gov’t Actions Buoy European Start-Ups
Susan Aldridge, Ph.D.
|
|
Enforceable Diagnostic Method Patents
Edmund R. Pitcher
Brian A. Fairchild, Ph.D.
|
|
Deficiencies in Forensic Science Training Must Be Met Head-On
Richard E. Bisbing
|
|
Initiatives Advancing Chilean Life Sciences
Robert Yuan, Ph.D.
|
|
New and Old Technologies Boost Advances
Sophia Fox
|
|
Schizophrenia Research with Real Time PCR
|
|
Strategies for Measuring Viable Biomass
John Carvell
|
|
Measurement of Global DNA Methylation
Deborah L. Vassar
Ernest J. Mueller, Ph.D.
Savita Bagga, Ph.D.
|
|
Staying Ahead of Activist Stockholders
Joseph E. Gilligan
Brian C. O'Fahey
|
|
| March 15, 2009 (Vol. 29, No. 6) |
|
Working with Cryopreserved Hepatocytes
Ji Young Lee, Ph.D.
Timothy A. Moeller
|
|
Combating Hospital-Acquired Infections
Bruce Carlson
|
|
Honing In On Fatty Liver Disease Treatment
Joe Levit
|
|
Madoff Matters, But Larger Issues Loom
Gail Dutton
|
|
Making Improvements to Standard of Care for HCV
Elizabeth Lipp
|
|
Advances in Label-Free Assay Screening
Patricia F. Dimond, Ph.D.
|
|
Protein Microarrays See Broader Utilization
K. John Morrow Jr., Ph.D.
|
|
Fledgling Firms Needed to Fill U.K. Void
Susan Aldridge, Ph.D.
|
|
U.S. Biofuels Market Off and Running
Ellyn Kerr
|
|
miRNA Profiling Opens Doors for New Drugs
Nina Flanagan
|
|
Maximizing Value in Outsourcing Services
Kathy Liszewski
|
|
Economic Crisis Provides a Potential Boost to IP Portfolio
Narinder S. Banait, Ph.D., J.D.
|
|
Determining Small Molecule Binding Kinetic Constants
|
|
GEN BIO Theater Presentations
|
|
microRNA Expression Profiling of Carcinomas of Unknown Origin
|
|
Novel OncoMouse Model
|
|
China Gains in Innovative R&D
|
|
Mycoplasma Contamination in Culture Media
Maik W. Jornitz
Theodore H. Meltzer , Ph.D.
|
|
Dissecting Protein-Protein Interactions
Eric J. Sundberg
|
|
Desorption Electrospray Ionization
Justin M. Wiseman
Peter T. Kissinger
|
|
| March 1, 2009 (Vol. 29, No. 5) |
|
Drug Absorption on Membrane Arrays
Voula Kodoyianni, Ph.D.
Christine Angevine, Ph.D.
|
|
Pharma’s Ongoing Quest for R&D Innovation
Carolyn Buck-Luce
Mark B. Hassenplug
|
|
Agilent Expands Its Capabilities in Robotics
Carol Potera
|
|
Researchers Map Neanderthal Genome
|
|
Revitalizing Surface Plasmon Resonance
Diana Gitig
|
|
TechNote: High-Throughput Kinase Selectivity Profiling
Mazen Karaman, Ph.D.
Dan Jones
Paul Gallant
|
|
Review: LabAuto Product Introductions
Ilene Schneider
|
|
Shining a Different Light on Genetic Diversity
Richard A. Stein, M.D., Ph.D.
|
|
Quality Makes a Difference in RNA Prep
K. John Morrow Jr., Ph.D.
|
|
DNA Vaccines Inch Toward Human Use
Gail Dutton
|
|
Grappling With Biologic Manufacturing Concerns
K. John Morrow Jr., Ph.D.
|
|
CMOs Hold Their Ground in Troubled Times
Angelo DePalma, Ph.D.
|
|
Quest for Fully Disposable Process Stream
Vicki Glaser
|
|
Business Continuity & Recovery Strategies
Merrilee Galloway
Mark Dyment
|
|
Personalized Medicine Grows in Fits and Starts
Lloyd Dunlap
|
|
Clinical Proteomics Heads Into Real World
N. Leigh Anderson, Ph.D.
|
|
Making the Most of Pre-IDE Meetings
Jeffrey Gibbs
|
|
China Stays Committed to Biodevelopment
Zhu Shen, Ph.D.
|
|
Standard Setting Increasingly Under Siege
Steven B. Pokotilow
Amy E. Wilson, Ph.D.
Benjamin P. Liu
|
|
Stem Cell Funding Roadblock
Bernard Siegel, J.D.
|
|
Measuring Multiplexed Signal Transduction
Shannon Henery
Thaddeus George
|
|
Low Metabolic Burden Plasmid Production
Aaron E. Carnes
James A. Williams
|
|
Impact of Risk Mitigation on Deal Market
Mark A. Metcalf
|
|
| February 15, 2009 (Vol. 29, No. 4) |
|
Second Messengers’ Accumulation Assays
Jean-Luc Tardieu, Ph.D.
|
|
Sky Could Be the Limit for DNA Testing
Bruce Carlson
|
|
Stratatech Builds on Cell Line Discovery
Carol Potera
|
|
PerkinElmer Retools Its Strategic Mission
Carol Potera
|
|
Case Study: Overcoming Antimicrobial Resistance
Ramin Najafi, Ph.D.
|
|
Does Offshoring Put Patents in Jeopardy?
Jeremy Minshull, Ph.D.
|
|
Low-Volume Liquid Handling Gaining Favor
Gail Dutton
|
|
Boosting Potential LC/MS Operations
Nina Flanagan
|
|
New Antibody Engineering Technologies
K. John Morrow Jr., Ph.D.
|
|
S. Korean Gov’t Nudges Biotech Along
Robert Yuan, Ph.D.
|
|
Pathway Knowledge Can Benefit Cancer Therapeutics
David Daniels, Ph.D.
|
|
Honing In on Targeted Resequencing
Kathy Liszewski
|
|
Overreacting to Perceived Risks
Henry I. Miller, M.D.
|
|
Recent Advances in NextGen Sequencing
|
|
Executive Interview: Reinhard Vogt, Sartorius Stedim Biotech
|
|
Modeling Ensemble Powers Systems Biology
Colin Hill
|
|
Peristaltic Aseptic Filling Instrumentation
Peter Lambert
Chuck Treutel
|
|
Tools That Facilitate Metabolite Identification
Yingying Huang, Ph.D.
|
|
| February 1, 2009 (Vol. 29, No. 3) |
|
Simplification of Kinase Binding Assays
Steven M. Riddle
|
|
miRNA Solidifies Role in Disease Research
Christianne Bird
|
|
CytImmune Banks on Gold Nanoparticles
Ilene Schneider
|
|
GEN’s Annual Wall Street Roundup
|
|
European Bioindustry Upbeat in the Long Term
Susan Aldridge, Ph.D.
|
|
Epigenomics Rises as Key Research Tool
Richard A. Stein, M.D., Ph.D.
|
|
Improving Delivery of RNAi Drugs
Nina Flanagan
|
|
Israeli Initiatives Seek to Sidestep Funding Crisis
Vicki Glaser
|
|
Uncovering Applications for DNA Forensics
Elizabeth Lipp
|
|
Alternatives to Mammalian Expression
K. John Morrow Jr., Ph.D.
|
|
Targeting Post-Translational Modifications
Angelo DePalma, Ph.D.
|
|
Raising Molecular Imaging to Higher Level
Gail Dutton
|
|
Strategies to Overcome Blood-Brain Barrier
Allan B. Haberman, Ph.D.
|
|
Chinese Outsourcing Nears Full Service
Jim J. Zhang, Ph.D.
|
|
Court Ruling May Impact Life Science Patents
Jeffrey D. Hsi
Elizabeth N. Spar
|
|
Venture Capital Firms Need Access to Government Coffers
J. Leslie Glick, Ph.D.
|
|
GEN’s MicroArray Challenge Solved
John Sterling
|
|
Promega's Protein Purification Project
|
|
Novozymes Exploits a Venerable Bioproduction Tool for Contract Manufacturing Operations
|
|
Visualizing Signal Transduction Pathways
Simon Fredriksson
|
|
GEN's Interview with Dr. Francisco J. Ayala
|
|
Accelerating Protease Drug Development
NIcholas J. Ede, Ph.D.
|
|
Three-Dimensional Cultivation of Cells
Hans Hoffmeister, Ph.D.
|
|
| January 15, 2009 (Vol. 29, No. 2) |
|
Tools for Studying Membrane Protein Targets
Soma S.R. Banik, Ph.D.
Christopher J. Laing, Ph.D.
Benjamin J. Doranz, Ph.D.
|
|
Capitalizing on Novel Expression Systems
Eric S. Langer
|
|
GenomeQuest Aims to Streamline Genomics
Carol Potera
|
|
Japanese BioAlliance Strategies Evolving
Tom Burger
James E. Foley, Ph.D.
|
|
Automation Drives Laboratory Economics
Catherine Shaffer
|
|
Identifying Best Practices for Advanced Therapies
Susan Aldridge, Ph.D.
|
|
Exploiting the Value of Cancer Biomarkers
Diana Gitig
|
|
Enhancing PCR for Diagnostic Applications
Lloyd Dunlap
|
|
Microfluidics Makes Strides to Fulfill Promise
Kathy Liszewski
|
|
Does Fusion Therapy Have a Role in Cancer?
John M. Pawelek, Ph.D.
|
|
Culture Media Underly Productivity Gains
Angelo DePalma, Ph.D.
|
|
Keeping the “Person” in Mind in Personalized Medicine
Peter Traber, M.D.
|
|
BD Biosciences Expands Capabilities in Cell Culture Media
|
|
Shut-off Switch for Cellulose Production Found
|
|
Finessing PI3 Kinase Assay Development
Kevin Entwistle
|
|
Minimizing Challenges in Biological Modeling
Kristen Zanella
|
|
Researchers Tackle Tumors One Cell at a Time
Frank Feist
|
|
Optimization of Binding Interaction Studies
Laura Moriarty, Ph.D.
|
|
Online Monitoring of In-Process Samples
Tanya Jenkins
|
|
| January 1, 2009 (Vol. 29, No. 1) |
|
High-Throughput Automation of DNA Extraction
David Saul, Ph.D.
Nick Price, Ph.D.
|
|
Fast Growth Foreseen for Protein Therapeutics
Andrea Hiller
|
|
Sequella Takes On Pernicious Enemies
Ilene Schneider
|
|
High-Content Screening Rapidly Evolving
David Daniels, Ph.D.
|
|
Linking Disease to Gene Variations
Vicki Glaser
|
|
Cautious Optimism Prevails for Chinese Biotechnology
Gail Dutton
|
|
Exploring the Human Proteome in Depth
Elizabeth Lipp
|
|
Utilization of DNA Microarrays Increasing
K. John Morrow Jr., Ph.D.
|
|
Peptide Capacity Holding Steady For Now
Vicki Glaser
|
|
Stem Cells Continue March Toward Clinic
Nina Flanagan
|
|
Korea Lays Groundwork for Future Success
Robert Yuan, Ph.D.
|
|
Update on Patent Law Revisions in China
Lisa A. Haile, J.D., Ph.D.
|
|
Will New Appointment Wax Healthcare Reform?
Rod Raynovich
|
|
Beijing Institute of Genomics Expands Applications for Life Technologies’ SOLiD System
|
|
Technology Showcase for New Screening Software
|
|
Celebrating Charles Darwin in 2009
John Sterling
|
|
Impact of Ultrafiltration of Hydrolysates
Tobi Limke, Ph.D.
|
|
Tritiated Opiate Receptor Radioligands
Crist N. Filer, Ph.D.
|
|
Assessing a Company’s Financial Health
David Sable, M.D.
|
|
| December 1, 2008 (Vol. 28, No. 21) |
|
Utilization of an Automated Triplex Assay
Andrew Niles
Simon T.M. Allard, Ph.D.
Jason Greene
Sarah Shultz
|
|
Moving Flow Cytometry Beyond Core Facilities
Madhu Sharma, Ph.D.
|
|
Tripos International Returns to Its Roots
Carol Potera
|
|
Q&A: Life Technologies Formed from AB/Invitrogen
David Daniels, Ph.D.
|
|
Doubts Stymie Implementation of RFID
Angelo DePalma, Ph.D.
|
|
Zeroing in on PI3K Pathway
Nina Flanagan
|
|
Spain Invests in Quest for Big Biotech Payoff
Sue Pearson, Ph.D.
|
|
Flow Cytometry Applications Proliferate
Sophia Fox
|
|
Update on Emerging Biobanking Practices
Catherine Shaffer
|
|
Improving Delivery thru Nanotechnology
Gail Dutton
|
|
Status of Biosimilars in U.S. Could Soon Change
Veronica Mullally
|
|
Tips on How to Properly Construe Patent Claims
John P. Iwanicki
|
|
Vilification of Bovine Growth Hormone Udderly Unwarranted
Henry I. Miller, M.D.
|
|
New FC Systems Measure More Variables Over Shorter Time Periods
K. John Morrow Jr., Ph.D.
|
|
Methylation-Sensitive Hi-Res Melting Analysis
Cameron N. Gundry
Mikeal Wall
Jason T. McKinney
Colleen Hough, Ph.D.
Lindsey Cutler
John D. Phillips, Ph.D.
Margaret K. Yu, M.D.
David H-F Teng, Ph.D.
|
|
Optimizing Mammalian Cell Culture Performance
Sally Grosvenor
|
|
Taking Old & New Molecules Down Novel Paths
Stephen R. Byrn, Ph.D.
|
|
Sourcing Well-Characterized Biospecimens
Samir Alhasan, Ph.D.
Shannon Richey
Apurvi Desai
|
|
Biotech’s Umbilical Cord Has Been Severed
Peter Winter
|
|
| November 15, 2008 (Vol. 28, No. 20) |
|
Use of a Nano-Structured Proteomic Biochip
Anna A. Fisher, Ph.D.
James C. Nelson, Ph.D.
David Ure
|
|
GPCR Market Exhibits Rapid Diversification
Ken Rubenstein, Ph.D.
|
|
Aiming to Accelerate Discovery Process
Carol Potera
|
|
Methodology Garners Researchers’ Interest
Carol Potera
|
|
New Zealand Biotech Poised for Growth
Janet Mason
|
|
Achieving Success in Tox Studies
Gail Dutton
|
|
Synthetic Biology Finds a Niche in Fuel Alternatives
Elizabeth Lipp
|
|
Understanding the Biology of RNAi
Lloyd Dunlap
|
|
Single-Use Filtration Hits the Mainstream
Angelo DePalma, Ph.D.
|
|
Adroit Crafting of “Intended Use” Critical
Jeffrey Gibbs
|
|
Outsourcing Medicinal Chemistry Activities
Vicki Glaser
|
|
Industry Briefing: Adapting to a Transformed Economic World
Susan Aldridge, Ph.D.
|
|
Amylin Builds on the Success of Byetta
Querida Anderson
|
|
New Treatment Strategies for Inflammation Gain Ground
Yuval Cohen
|
|
Structure of Critical GPCR Determined
|
|
Companies Collaborate to Provide Integrated Solution to Preclinical Laboratory Workflow
|
|
LIMS Addresses Major Biobanking Challenges
Doug Holbrook
|
|
Off-Gas Analysis for Real-Time Process Control
Karin Koller
|
|
Chromatographic Column Characterization
Michael McBrien
|
|
| November 1, 2008 (Vol. 28, No. 19) |
|
Automating Cell Culture Operations in R&D
Lara Marchetti, Ph.D.
|
|
Photonics Poised to Cross Over into Biotech
Andrea Hiller
|
|
Firm Invests in New HIV Vaccine Strategy
Carol Potera
|
|
Removing Antigen Discovery Guesswork
Carol Potera
|
|
Waging a Multipronged Alzheimer’s War
Vicki Glaser
|
|
MS Sample Prep–Challenges and Pitfalls
K. John Morrow Jr., Ph.D.
|
|
Critical Issues When Selecting a CMO
Eric S. Langer
|
|
Accelerating Research into Clinical Setting
Winston Patrick Kuo, D.D.S., D.M.Sc.
Robert J. Distel, Ph.D.
|
|
Identifying Biochemical Threats Earlier
Gail Dutton
|
|
Latin American Biotech Steadily Emerges
Bruce F. Mackler, Ph.D., J.D.
|
|
qPCR Methods Expand Rapidly
David Daniels, Ph.D.
|
|
Vaccine Development Aided by New Techniques
Angelo DePalma, Ph.D.
|
|
Is Safe Harbor Closed to Research Tools?
William L. Warren
Donna Best
|
|
Quo Vadis Biofuels Projects?
Michael S. Koeris, Ph.D. Student
|
|
Biofuel Standards
|
|
DNA Vaccines Meeting
|
|
New Multiplex Approach for Rapid Diagnostics
|
|
Production of High Secretion Cell Lines
Imran Clark, Ph.D.
HaYong Lim
Kristi Hohenstein, Ph.D.
Gary Bright, Ph.D.
|
|
mRNA Analysis with Next-Gen Sequencing
Gary P. Schroth, Ph.D.
|
|
Unfulfilled Promise of Predictive Toxicology
Joseph Zock
Rebecca J. Palmer
|
|
Using Microdosing to Enhance Development
Graham Johnson, Ph.D.
|
|
Preparing for a Shrinking Economic World
Daniel Ruppar
|
|
| October 15, 2008 (Vol. 28, No. 18) |
|
High-Throughput Live-Cell Imaging Assays
Carolyn Conant, Ph.D.
|
|
Animal Therapeutics and Diagnostics
Melissa Elder
|
|
Taking DNA-Guided Medicine to the Clinic
|
|
Engineering Droplets for DNA Sequencing
Carol Potera
|
|
Cashing in Your Chips to Advance Discovery
K. John Morrow Jr., Ph.D.
|
|
Benefits of Integrating IT and Team Building
David Dunn
|
|
Strengthening Mammalian Cell Culture
Angelo DePalma, Ph.D.
|
|
Exploiting Advances in Image Analysis
Richard A. Stein, M.D., Ph.D.
|
|
Regenerative Therapies Gain Momentum
Elizabeth Lipp
|
|
Deciphering Biological Networks
Kathy Liszewski
|
|
Fine-Tuning the Design of GPCR Therapeutics
Carol Potera
|
|
Patent Update: Redefining Written Descriptions for Patents
William L. Warren
Mark Westhafer, Ph.D.
|
|
VC Funding for Biotech Firms
J. Leslie Glick, Ph.D.
|
|
What's Driving Dealmaking in Biopharma?
|
|
Advanced Imaging Applications
Richard A. Stein, M.D., Ph.D.
|
|
Screening Test for Traumatic Brain Injury
Galina Bernstein, Ph.D.
Wei Hu, Ph.D.
|
|
Validation of Protein Quantification Assays
Katja Aschermann, Ph.D.
Martin Blüggel
Andreas Wattenberg, Ph.D.
|
|
Taking Aim at Gene-Regulation Research
Constanze Kindler, Ph.D.
|
|
Expediting Purification of Cellular Proteins
Manfred Koegl, Ph.D.
|
|
| October 1, 2008 (Vol. 28, No. 17) |
|
Quantifying Cell Migration and Invasion
Keren I. Hulkower, Ph.D.
Maria Perr
|
|
Lipid-Modifying Therapies Face Flat Sales
Sreten Bogdanovic, Ph.D.
|
|
ZyGEM Builds DNA Extraction Kit Portfolio
Carol Potera
|
|
Bacteriophage-Based Antibiotic Therapy
Carol Potera
|
|
Opinion: Reining In New Therapeutic Hype Is Critical
Michael Feehan, Ph.D.
Rich Durante, Ph.D.
|
|
Protein Quantification Pinpoints Targets
K. John Morrow Jr., Ph.D.
|
|
Predicting Adverse Drug Reactions
Susan Aldridge, Ph.D.
|
|
FDA Pushes PAT and Companies Shove Back
Eric S. Langer
|
|
Cell Imaging Makes Strides in Drug R&D
Nina Flanagan
|
|
Biomarker Assay Use Increases
Lloyd Dunlap
|
|
CMOs See Robust Growth
William Downey
|
|
Redefining Obviousness After KSR Decision
George C. Yu
John Kappos
|
|
Substantive Progress Is Being Made in Breast Cancer Survival
Judith-Anne Chapman, Ph.D.
|
|
Novel Cell Culture Optimization Strategy
Cindy Neely, Ph.D.
|
|
Enzyme Immobilization on Polymeric Resins
Jon Fisher
|
|
Tools for Enhancing Vitamin D Therapeutics
Christian Helvig, Ph.D.
Martin Petkovich, Ph.D.
|
|
Targeted Genome Editing via ZFN Methodology
Greg Davis, Ph.D.
Trevor Collingwood, Ph.D.
Phil Simmons
|
|
Molecular Diagnostics Take Center Stage
Rod Raynovich
|
|
| September 15, 2008 (Vol. 28, No. 16) |
|
Assay Tools for Nuclear Hormone Receptor Studies
Mahesh Mathrubutham, Ph.D.
Patricia Whaley, Ph.D.
Tom Wehrman, Ph.D.
Keith Olson, Ph.D.
|
|
Pitfalls Undermine Promise of Theranostics
Kenneth P. Krul, Ph.D.
|
|
Chemical Firm Enters Biopharma CMO Sector
Susan Aldridge, Ph.D.
|
|
Firm’s Pipeline Targeted at HPV and Cancer
Carol Potera
|
|
Biotech Crops Directly Tied to Higher Yields
Terry Wanzek
|
|
Capitalizing on the RNAi Space Expansion
Elizabeth Lipp
|
|
Metabolite Profiling Speeds Diagnostic Efforts
K. John Morrow Jr., Ph.D.
|
|
Disposable Use Proliferates in Production
Angelo DePalma, Ph.D.
|
|
Users Are Sold on Single-Use Systems
Eric S. Langer
|
|
Refining Protein Drug Formulation
David Daniels, Ph.D.
|
|
FDA Backs PAT to Help Solve Manufacturing Woes
Lloyd Dunlap
|
|
RNAi’s Potential Is Spurring Alnylam’s Value
Querida Anderson
|
|
Thwarting Domestic Terrorism
Henry I. Miller, M.D.
|
|
Using Metabolomics in Biomarker Discovery
Walter E. Gall, Ph.D.
|
|
mAb Capture from Unclarified Feedstock
Allan Lihme
Rob Noel, Ph.D.
|
|
Standard Materials for Clinical Proteomics
Peter Schulz-Knappe
|
|
Improving High-Res Mass Spec Formula ID
Don Kuehl
|
|
| September 1, 2008 (Vol. 28, No. 15) |
|
Proficient Use of Sandwich Antibody Arrays
Roberto Campos-Gonzalez, Ph.D.
Kathy Brumbaugh, Ph.D.
Dave Finkel
Greta Wegner, Ph.D.
Jackie Ernst
|
|
Nucleic Acid Purification Market Expands
Christianne Bird
|
|
Platform Simulates Human Capillaries
Carol Potera
|
|
Delivery of Time-Lapsed Live-Cell Imaging
Carol Potera
|
|
Peptide Drugs Becoming More Prevalent
Vicki Glaser
|
|
In-Line Analytics Improve Manufacturing
Gail Dutton
|
|
Cell Counting and Process Monitoring
Susan Aldridge, Ph.D.
|
|
USPTO Backlog Impacts Biopharma Industry
Anthony Tridico
Jim Kastenmayer
Ali Kargbo
|
|
Makeover Mandated for U.K. Life Science Sector
Sophia Fox
|
|
Marketing Analysis: What Is the Future of DTC Drug Advertising?
Wendy Macias, Ph.D.
|
|
Roundtable Discussion: Future High-Throughput Screening Directions
|
|
Next-Generation Sequencing Update
Richard A. Stein, M.D., Ph.D.
|
|
Improving R&D as well as Disease Prognosis
Nina Flanagan
|
|
Creative Applications of qPCR Proliferate
Catherine Shaffer
|
|
FDA Seeks to Establish Branch Office in China
Gail Dutton
|
|
Bio Directive Fails to Unify European Law
Matthew Royle
Gareth Morgan
Simon Cohen
|
|
Undermining Scientific Credibility
Alan McHughen, Ph.D.
|
|
Sample Quantitation with Microvolume Tools
Joel Hansen, Ph.D.
Philippe Desjardins
|
|
Finding Proteins in Cell-Conditioned Media
Judith Nagy, Ph.D.
Yunyi Kang
Anthony Cass
Athanasios Mantalaris
|
|
Automated Purification for Genetic Trait Maps
Jethro Holter
Tone Yrvum
|
|
Spiral Countercurrent Chromatography
Martha Knight, Ph.D.
|
|
Digital Pathology in Preclinical Research Arena
Steve Potts, Ph.D.
|
|
VC Funding for Biotech Companies Withering
Robert Dellenbach
|
|
| August 1, 2008 (Vol. 28, No. 14) |
|
Achieving Precision Analysis with ELSD
Simon Robinson
|
|
Pharma Outsourcing on Upward Trajectory
Bruce Carlson
|
|
SRI Boasts Abilities in Early- and Late-Stage R&D
Carol Potera
|
|
Company Touts Its Novel Sequencing Technique
|
|
Is the U.K. Biotech Industry on the Skids?
Sue Pearson, Ph.D.
|
|
Antibody Processing Platforms Evolve
K. John Morrow Jr., Ph.D.
|
|
Flexibility Crucial in Bioreactor Systems
Elizabeth Lipp
|
|
Regulatory Pathways for Molecular Dx
Jeffrey Gibbs, Esq.
|
|
A Sensible Approach to Interpreting Research
Elizabeth M. Whelan, M.D.
|
|
Strengthening the Biotechnician Workforce
John Sterling
|
|
GEN Review BIO 2008: Tips for Doing Business in China and India
Gail Dutton
|
|
GEN Review BIO 2008: Grappling with the Regulation of Biosimilars
K. John Morrow Jr., Ph.D.
|
|
GEN Review BIO 2008: News from the Floor of BIO's Annual Meeting
|
|
Roundtable Discussion: High-Throughput Screening Challenges
|
|
Novel Approaches to Lead Optimization
Elizabeth Lipp
|
|
Protein Analysis Technologies Overview
Vicki Glaser
|
|
Applicability of Biomarkers Is Far-Reaching
David Daniels, Ph.D.
|
|
Ancillary Analysis Tools for Microarrays
Sophia Fox
|
|
Novel MS Systems Expedite Workflow
Gail Dutton
|
|
Platform Technologies Ease Scale-Up Pain
Angelo DePalma, Ph.D.
|
|
Batch Failure Rates in Biomanufacturing
Eric S. Langer
|
|
Graduate Programs that Prepare for NonResearch Careers
Molly B. Schmid
|
|
Advancing Gene Expression Studies
Lloyd Dunlap
|
|
Monoliths Emerge as Key Purification Methodology
Pete Gagnon
|
|
Enforceability of Patent Licenses Under Fire
Courtenay C. Brinckerhoff
|
|
Successful Genetic Tests Are Predicated on Clinical Utility
Diane Allingham-Hawkins, Ph.D.
|
|
Small-Scale Parallelized Biochromatography
Lothar Britsch, Ph.D.
Tim Schroeder
Jurgen Friedle, Ph.D.
|
|
Making Antibiotics Obsolete in Fermentation
Daniel Stieber, Ph.D.
Philippe Gabant, Ph.D.
Cedric Szpirer, Ph.D.
|
|
Fast PCR with Long and Difficult Amplicons
Haiyang Grunenwald, Ph.D.
|
|
Measurement of Proteins in FFPE Tissue
Casey Eitner
David B. Krizman, Ph.D.
|
|
| July 1, 2008 (Vol. 28, No. 13) |
|
Bioluminescent Assays for Potency Assessment
Sarah Schultz
Andrew Niles
Jey Cheng, Ph.D.
Simon T.M. Allard, Ph.D.
|
|
Adoption of Molecular Diagnostics Slowing
Kevin Leong
|
|
Firm's Bailiwick Based on Protein-Protein Expertise
Carol Potera
|
|
Compound Discovery Tools Still Evolving
Elizabeth Lipp
|
|
Can In Silico Modeling Speed Development?
K. John Morrow Jr., Ph.D.
|
|
Biomagnetic Separations See Increased Use
Gail Dutton
|
|
Reducing Downstream Purification Costs
Angelo DePalma, Ph.D.
|
|
Peptide Boom Puts Pressure on Synthesis
Susan Aldridge, Ph.D.
|
|
Staying Ahead of Upstream Developments
Susan Aldridge, Ph.D.
|
|
Quantifying Downstream Capacity Crunch
Eric S. Langer
|
|
Primer on Regulation of Diagnostic Assays
Jeffrey Gibbs, Esq.
|
|
Conquering RNAi Delivery Challenges
Kathy Liszewski
|
|
Sample Prep Initiatives Will Advance Proteomics
Nina Flanagan
|
|
Preventing Discord in Research Collaborations
Stewart Lyman, Ph.D.
|
|
Trends in Synthesis and Manufacturing
Diana Gitig
|
|
Recasting the Federal Debate on Stem Cells
Joseph R. Sollee
|
|
GINA Provides Bioindustry Boost
Sharon Terry
Joann Boughman, Ph.D.
|
|
Assay: Avoiding Interference in Immunoassays
Tobias Polifke, Ph.D.
Peter Rauch, Ph.D.
|
|
Choosing a Normalization Strategy for RT-PCR
Anders Bergkvist
Amin Forootan
Neven Zoric
Linda Strombom
Robert Sjoback
Mikael Kubista
|
|
Focusing on Task of Reinventing Peptide Drugs
Warren P. Levy, Ph.D.
|
|
Strategies for Streamlining Bioproduction
Jill Staggert
|
|
The Paradox of Biotechnology Value Investing
David Sable, M.D.
|
|
| June 15, 2008 (Vol. 28, No. 12) |
|
Planning for Success in Biomarker Discovery
Enrique A. Dalmasso, Ph.D.
|
|
SNPs—A Shortcut to Personalized Medicine
Bruce Carlson
|
|
Almac Offers a Range of Integrated Services
Susan Aldridge, Ph.D.
|
|
Overcoming Complications in Multiplexing
Catherine Shaffer
|
|
Managing Asthma and COPD Treatments
Sue Pearson, Ph.D.
|
|
TechUpdate: Are Lentiviral Vectors on Cusp of Breakout?
Tim Ravenscroft
|
|
Turning Research into Viable Cancer Drugs
John F. Wong, Ph.D.
|
|
Tackling Drug-Interaction Issues Early On
Elizabeth Lipp
|
|
Finding Balance in Cell-Line Development
Angelo DePalma, Ph.D.
|
|
Methods for Maximizing Antibody Yields
K. John Morrow Jr., Ph.D.
|
|
Optimizing Utilization of Biomarkers
Kathy Liszewski
|
|
Flexibility Is the Name of the Game for CROs
Lloyd Dunlap
|
|
Osiris Trumpets Its Adult Stem Cell Product
Querida Anderson
|
|
No Member of Congress Left Behind
Henry I. Miller, M.D.
|
|
Counting Chromosome Copy Numbers Efficiently
Roland Kirchner, Ph.D.
Claudia Holzhauer
Frank Feist
Wolfgang Mann, Ph.D.
Marianna Alunni-Fabbroni, Ph.D.
|
|
Improving Synthetic Oligo Purification Process
Gregory Scott
Cathy Cordova
Michael McGinley
|
|
| June 1, 2008 (Vol. 28, No. 11) |
|
Cell Signaling Analysis Using Multiplex Assays
Scott Hayes, Ph.D.
Robyn M. Perrin, Ph.D.
|
|
Adults Now Drive Growth of Vaccine Market
Bruce Carlson
|
|
Novel Treatment Approach Leverages Epigenetics
Carol Potera
|
|
RNAi Researchers Galvanized by Advances
Elizabeth Lipp
|
|
Interrupting Protein-Protein Interactions
Diana Gitig
|
|
PAT Initiative Helps Move HPLC Forward
Angelo DePalma, Ph.D.
|
|
Norway's Oncology Efforts Are Coalescing
Susan Aldridge, Ph.D.
|
|
BioInsights: Biotech Industry Success Powered by Innovation
James C. Greenwood
|
|
Superbugs vs. Superdrugs: Race Goes On
Sue Pearson, Ph.D.
|
|
Ion Channels Play Key Role in R&D
David Daniels, Ph.D.
|
|
Digging for Insights through High-Content Data Mining
Gail Dutton
|
|
Off-Label Promotion Under Scrutiny by DOJ
Peter S. Spivack
|
|
Recreational Ancestry–Caveat Emptor?
Jonathan Marks, Ph.D.
|
|
Dispersive Raman Spectroscopy Utilization
Nesredin A. Mussa, Ph.D.
Benjamin P. Locwin
|
|
Honing In on Chemoresistance Pathways
Michael D. Becker
|
|
Observing Stem Cell Growth and Viability
Jennifer L. Peters, Ph.D.
William E. Jastromb
|
|
Inducement of Gene Expression or Silencing
Sanjay Vasu, Ph.D.
Jian-Ping Yang, Ph.D.
Adam N. Harris, Ph.D.
Wieslaw Kudlicki, Ph.D.
|
|
Tips for Emerging Firms on Obtaining Funding
Barbara Schilberg
|
|
| May 15, 2008 (Vol. 28, No. 10) |
|
Strategy to Improve Quantitative Telomere FISH
Rajiv Raja, Ph.D.
Zuguo Li, Ph.D.
Yun-Ling Zheng, Ph.D.
|
|
Demand for Novel Delivery Systems Rising
Bill Martineau
|
|
Company Seeks to Shake Up Protein Analysis
Sophia Fox
|
|
Symbiotic Firms Zero In on Enzymatic Tools
Carol Potera
|
|
Optimizing the Profiling of Protein Kinases
Patricia F. Dimond, Ph.D.
|
|
ELNs Ready for Large-Scale Deployment
Gail Dutton
|
|
Quest for Cancer Therapeutics Redirected
Irena Melnikova, Ph.D.
|
|
Applying aCGH to Molecular Diagnostics
Kathy Liszewski
|
|
Mass Spec Solidifies Discovery Role
Nina Flanagan
|
|
Filling Oligo Production Void
Vicki Glaser
|
|
Mannkind Persists with Inhaled Insulin
Querida Anderson
|
|
Genetic Science Confounds Students
Kenna Shaw, Ph.D.
Katie Van Horne
Joann A. Boughman, Ph.D.
|
|
Politically Speaking: Candidates Opine on Biotech & Health Issues
|
|
Obstacles to Presterilized Single-Use Filling
Jeff Jackson
|
|
Applications of New Synthesis Technologies in Drug Discovery and Development
William J. Blake, Ph.D.
Andy Rakestraw, Ph.D.
Patti M. Aha
|
|
| May 1, 2008 (Vol. 28, No. 9) |
|
Site-Specific Phosphorylation Profiling
Tim Nadler, Ph.D.
Ed Machuga
|
|
“Active” Products Drive Wound-Care Market
Toby Zaleski, Ph.D.
|
|
Targeting Diabetes-Related Heart Disease
Carol Potera
|
|
Search Continues for Injection Alternatives
Susan Aldridge, Ph.D.
|
|
Capitalizing on Abundant Opportunities in Wales
Susan Aldridge, Ph.D.
|
|
Introducing In Vitro ADMET Studies Earlier
David Daniels, Ph.D.
|
|
GPCRs Remain “Hot” Drug Targets
Elizabeth Lipp
|
|
Bioprocess Advances Aim to Streamline Operations
Vicki Glaser
|
|
Versatility Concerns Impact Facility Design
Angelo DePalma, Ph.D.
|
|
Quantification & Identification in Proteomics
Vicki Glaser
|
|
Tools for Protein Structure Characterization
K. John Morrow Jr., Ph.D.
|
|
Court Blocks PTO-Initiated Patent Reform
Courtenay C. Brinckerhoff
|
|
Cancer Stem Cells: Fact or Fiction
George L. Gabor Miklos, Ph.D.
Phillip J. Baird, M.D., Ph.D.
Ian E. Haines, M.D.
|
|
Boosting Microplate Reader Functionality
Franka Ganske, Ph.D.
Michael Fejtl, Ph.D.
Marjan Orban, Ph.D.
|
|
Use of Continuous Plate Reactor Technology
Barry Johnson, Ph.D.
Johan Persson
Tom Thane Nielsen
|
|
Biosimilars Are Poised to Influence the Industry
Viren Mehta, Pharm.D.
Eric Snyder, Ph.D.
|
|
| April 15, 2008 (Vol. 28, No. 8) |
|
Combining Microscopy with In Vivo Imaging
Timothy Alan Sutton, M.D., Ph.D.
Kenneth William Dunn, Ph.D.
|
|
Cell-Based Assay Utilization Is On the Upswing
Shankar Sellappan, Ph.D.
|
|
Anthill Addresses Chemical Synthesis Needs
Carol Potera
|
|
Emerging Firms Highlighted at Roth Meeting
Ilene Schneider
|
|
Cell-Based Assay R&D Role Expands
Kathy Liszewski
|
|
Downstream Bottlenecks: Are They Myth or Reality?
Gail Dutton
|
|
HTS Carving Out Hit-to-Lead Position
Nina Flanagan
|
|
Roche All Set to Launch xCELLigence System
John Sterling
|
|
Increasing Yield in Nucleic Acid Sample Prep
Vicki Glaser
|
|
Managing Data from Next-Gen Sequencing
William Van Etten, Ph.D.
|
|
Creating a Life Science Cluster in Florida
Tamlyn Oliver
|
|
Celera Readies Itself for Possible Spin-Off
Querida Anderson
|
|
Using DNA Traceability to Track Meat and Ensure Safety
Patrick Cunningham, Ph.D.
|
|
Quantifying Pipette Variability due to Humidity
Doreen Rumery
|
|
Producing Proteins for New Drug Development
Soon Seog Jeong, Ph.D.
Hui Feng, Ph.D.
Gabriel Cubberley
Maria Borovilos
|
|
Development of an Ion-Exchange Process
Anthony R. Newcombe, Ph.D.
Claire Newcombe
Richard Francis
|
|
| April 1, 2008 (Vol. 28, No. 7) |
|
Studying Protein Interactions in Living Cells
Ryan D. Bomgarden, Ph.D.
|
|
Aging ELISA Realm Takes Benchmark Role
Christianne Bird
|
|
Increasing the Odds of In Vitro Fertilization
Carol Potera
|
|
Saskatchewan Looks Past AgBiotech Roots
Carol Potera
|
|
Cancer Biomarkers Expedite Detection
K. John Morrow Jr., Ph.D.
|
|
Regulations Still Driving Stability Testing
Angelo DePalma, Ph.D.
|
|
Revolutionizing Protein Expression in R&D Arena
Elizabeth Lipp
|
|
Metabolomics Studies Rise in Quality
Susan Aldridge, Ph.D.
|
|
New Solutions Make qPCR a Rapidly Advancing Field
David Daniels, Ph.D.
|
|
U.S. Gene Patents in Legal Limbo –– for Now
Janis K. Fraser, Ph.D.
|
|
Defending Pharma Companies
J. Leslie Glick, Ph.D.
|
|
Removing Color Impurities in Biomanufacturing
Jon Fisher
Amie Gehris
John Maikner
|
|
Biobanks Can Make or Break Biomarkers
Kevin Krenitsky, M.D.
|
|
Combined Correctness Can Enrich Proteomics
Ola Forsstrom-Olsson
Anna Kapferer
|
|
Alzheimer’s Market Set to Grow Substantially
Rod Raynovich
|
|
| March 15, 2008 (Vol. 28, No. 6) |
|
Machine Vision Improves HTS Quality Control
Jason Cassaday
|
|
Growth Foreseen for Ophthalmology Sector
Hermann A. M. Mucke, Ph.D.
|
|
Fermentas Learned Fast How to Go Global
Ilene Schneider
|
|
Cellectar’s 3-Step Process to Target Tumors
Carol Potera
|
|
Funding Issues Stymie Pandemic Preparation
Sue Pearson, Ph.D.
|
|
Getting More Out of Poor RNA Samples
Kathy Liszewski
|
|
Applications Broaden for Epitope Mapping
K. John Morrow Jr., Ph.D.
|
|
New Products Expand Use of Disposables
Angelo DePalma, Ph.D.
|
|
Fragment-Based Approach Increases Leads
Elizabeth Lipp
|
|
Surmounting Small Molecule Challenges
Nina Flanagan
|
|
Automating and Unifying Lab Workflow
Ilene Schneider
|
|
Protein Microarray Uses Abound
Vicki Glaser
|
|
CROs Step Up Activities in Developing Countries
Gail Dutton
|
|
Paucity of Biopharma Approvals Raises Alarm
Ronald A. Rader
|
|
Monogram Enters Theranostic Market
Querida Anderson
|
|
Designing Improved Humans
Henry I. Miller, M.D.
|
|
Fine-Tuning Compound Safety Assessments
Richard Brennan, Ph.D.
|
|
Identifying MRSA with Multiplex Sequencing
T. Vinayagamoorthy, Ph.D.
Roger Hodkinson
|
|
Metabolic Monitoring Enhances Production
Bo Xu, Ph.D.
Jens Gram, Ph.D.
|
|
| March 1, 2008 (Vol. 28, No. 5) |
|
Development of a Real-Time Immunoassay
Jean-Francois Houle, Ph.D.
Paul Smith
|
|
qRT-PCR Ready for Rapid Growth Worldwide
Shankar Sellappan, Ph.D.
|
|
Solutions for Automating a Cell Culture Process
Susan Aldridge, Ph.D.
|
|
Staying Focused on Rodent-Breeding Business
Carol Potera
|
|
Life Science Compensation Trends Upward
Bryan Pearce
|
|
Oulu Region Lures Biotechnology Firms
Susan Aldridge, Ph.D.
|
|
Tapping miRNA-Regulated Pathways
Vicki Glaser
|
|
Small Biotechnology Firms Reach Out to CROs for Help
Nina Flanagan
|
|
Pharmaceutical Manufacturing Goes Green
Vicki Glaser
|
|
Innovations Mark Biosensor Development
K. John Morrow Jr., Ph.D.
|
|
Next-Generation Sequencing Picks Up Pace
Lloyd Dunlap
|
|
Optimizing Transient Gene Expression
K. John Morrow Jr., Ph.D.
|
|
Diagnostics Advancing Healthcare Reform
John F. Wong, Ph.D.
|
|
Protecting Inventions in the U.S. and Europe
Courtenay C. Brinckerhoff
|
|
“MAP” for Improving Drug Testing
John J. Pippin, M.D.
|
|
Stabilizing Protein-Folding Conformations
Gene W. Lee, Ph.D.
|
|
Versatile, Label-Free Microarray Analysis
Voula Kodoyianni, Ph.D.
|
|
Tool Firms Set Up to Defy Economic Downturn
John L. Sullivan
|
|
| February 15, 2008 (Vol. 28, No. 4) |
|
Increasing Specificity in Transporter Assays
Ismael Hidalgo, Ph.D.
|
|
Pediatric Market Offers Multiple Opportunities
Bruce Carlson
|
|
Automating Clone Picking in Bioproduction
Susan Aldridge, Ph.D.
|
|
BrainCells Bets on Small Molecule Therapies
Ilene Schneider
|
|
LC Applications Are Expanding
Angelo DePalma, Ph.D.
|
|
Top 60 Chinese Biofirms Propel Industry Forward
Eliza Yibing Zhou
|
|
Lab-Asset Management Gets Smarter
Gail Dutton
|
|
Improving Service-Provider Performance
Michael Webster
|
|
Tips for Building a Core Genotyping Facility
Vicki Glaser
|
|
Novel Approaches to Engineer Antibodies
K. John Morrow Jr., Ph.D.
|
|
London Strives to Be Global Biotech Hub
Susan Aldridge, Ph.D.
|
|
Partnerships Expedite Product Advancement
Stewart Lyman, Ph.D.
|
|
Patients Shortchanged by Big Pharma
Marc-André Gagnon
|
|
Industrial Manufacturing of Plasmid DNA
Hans Huber, Ph.D.
Wolfgang Buchinger, Ph.D.
Josef Diewok, Ph.D.
Robert Ganja
Daniela Keller
Jochen Urthaler, Ph.D.
Roman Necina, Ph.D.
|
|
SNP Genotyping Aids Diagnostic Development
Steven Dodsworth, Ph.D.
|
|
Hastening Epitope Discovery for Vaccines
Nikolai Schwabe, Ph.D.
Amanda Turner
|
|
| February 1, 2008 (Vol. 28, No. 3) |
|
Company Update: Protagen Zeroes In on Protein Therapeutics
Sophia Fox
|
|
Trubion Tackles Second-Generation mAbs
Carol Potera
|
|
GEN’s Annual Wall Street Analyst Roundup
|
|
BioMarket Trends: Phalanx of Treatments Propels Burn Market
Bruce Carlson
|
|
DNA Methylation Bolsters Cancer Research
Nina Flanagan
|
|
Winning the Contamination Control Battle
Angelo DePalma, Ph.D.
|
|
Stem Cells Advance on Multiple Fronts
Elizabeth Lipp
|
|
Driving Discovery from Inside Out
Kathy Liszewski
|
|
qPCR Poised for Prime Time
Lloyd Dunlap
|
|
New Act Endangers Long-Term Patent Validity
Beverly Lubit, Ph.D.
|
|
Firms Need to Focus on Profits
Henry I. Miller, M.D.
|
|
Streamlining Gene Delivery with Microporation
MinSung Kim
Neoncheol Jung, Ph.D.
|
|
Assay: Single-Molecule Sequencing Advances
Avak Kahvejian, Ph.D.
|
|
Combination Therapies Fortify Oncology Fight
Mark Hickinson, Ph.D.
Nate Cosper, Ph.D.
|
|
Aiming at Easier Scale-Up in Protein Production
Brian Dalby, Ph.D.
Chaoting Liu
Weixing Chen, Ph.D.
Henry C. Chiou, Ph.D.
|
|
Web Exclusive: GEN’s Annual Wall Street Roundup
|
|
| January 15, 2008 (Vol. 28, No. 2) |
|
Affitech Exploits Antibody Discovery Platforms
Susan Aldridge, Ph.D.
|
|
Company Update: GATC Solely Focused on Sequencing Services
Sophia Fox
|
|
Biomarket Trends: Molecular Diagnostics on the Move
Lucy J. Sannes, Ph.D.
|
|
Web Exclusive: Predicting the Future of the Bioreactor
Vijay Singh, Ph.D.
|
|
Tech Focus: Prognosticating the Future of the Bioreactor
Vijay Singh, Ph.D.
|
|
Turning Targets into Drug Products
Gail Dutton
|
|
Time-Resolved FRET Gains in Popularity
Kate Marusina, Ph.D.
|
|
Biobanking Needs More Standardized Procedures
Elizabeth Lipp
|
|
RNAi Gene Silencing Applications Advance
Vicki Glaser
|
|
Capitalizing on Biomarker Discovery Work
Trevor Stokes
|
|
Jump-Starting Bioprocessing Sector in U.K.
Susan Aldridge, Ph.D.
|
|
Changing Needs Drive the Media Market
Angelo DePalma, Ph.D.
|
|
Revamping Recovery & Purification Strategies
K. John Morrow Jr., Ph.D.
|
|
Improving Protection of Trial Participants
Jonathan E. Rackoff, J.D.
Namrata Kotwani
|
|
Optimizing the Rapid Production of Vaccines
Silke Fetzer
|
|
Establishment of a Sustainable Biobank
Steve Arsenault
Kerri McWeeny
Denis Bilodeau
Daniel Gaudet, M.D., Ph.D.
|
|
Novel Platform Enables Shotgun Proteomics
Brian M. Balgley, Ph.D.
Cheng S. Lee, Ph.D.
|
|
Assay: Hybrid Bridges the Microplate Reader Gap
Mickie Henshall
Paul Held, Ph.D.
|
|
| January 1, 2008 (Vol. 28, No. 1) |
|
Expanding Antibody Therapeutic Options
Carol Potera
|
|
BioMarket Trends: Orphan Drug Arena Driven by Biologics
Syamala Ariyanchira, Ph.D.
|
|
Tech Note: Delivery of Functional Proteins Inside Cells
Laurent Meunier, Ph.D.
Stephane Moutard, Ph.D.
Olivier Zelphati, Ph.D.
|
|
Addressing Unmet Type 2 Diabetes Needs
Allan B. Haberman, Ph.D.
|
|
Siemens’ Science and Technology Awards
|
|
Getting a Handle on Nanobiotech Products
Vicki Brower
|
|
High-Content Discovery Analysis
Kathy Liszewski
|
|
Repositioning Idle Drugs via Systematic Serendipity
Gail Dutton
|
|
Systems Biology Alters Drug Development
Nina Flanagan
|
|
Unlocking the Secrets of Protein Profiling
Elizabeth Lipp
|
|
Complex Peptides Challenge Manufacturers
Vicki Glaser
|
|
DTC Campaigns Mislead Public
Karina L. Brierley
Ellen T. Matloff
|
|
Assay: Mimicking Cellular Behavior in Capillaries
Kate Fitzgerald, Ph.D.
|
|
Total RNA Purification for Real-Time RT-PCR
Jasmin Gibson
Ken Doyle, Ph.D.
Julie Kramer
|
|
Integrity Testing of Large-Size Filter Systems
Matthew Daley
Jibin Hao
|
|
Making Personalized Medicine a Reality
Lisa A. Haile, J.D., Ph.D.
|
|
| December 1, 2007 (Vol. 27, No. 21) |
|
Novozymes Tackles Ingredient Manufacture
Carol Potera
|
|
Biomarket Trends: LIMS Growth Driven by Replacement Purchases
Jonathan Witonsky
|
|
Biotech Aims High in the Lone Star State
Vicki Brower
|
|
Erecting Exclusivity Barriers with Innovation
Douglas Martin, M.D.
|
|
Finding Your Place as an Industry Scientist
Tamara Zemlo, Ph.D.
|
|
ADMET Issues Slow Discovery
Elizabeth Lipp
|
|
Sample Storage Requires Regular Tweaking
Nina Flanagan
|
|
Broadening Genetic Tests in the Consumer Market
Kate Marusina, Ph.D.
|
|
Obstacles to Exploitation of miRNA Falling
Catherine Shaffer
|
|
Lyophilization Advances Improve Recovery
K. John Morrow Jr., Ph.D.
|
|
Enlisting CROs for Clinical Trial Assistance
Gail Dutton
|
|
Patent Ambushing Sullies Standard Setting
Wim Nauwelaerts
|
|
Antisocial Bio-Activism
Henry I. Miller, M.D.
|
|
High-Performance Melting Curve Analysis
Michael Hoffmann
Jochen Hurlebaus
Christian Weilke
|
|
Assay: Analyzing Lipid-Modifying Enzymes
Jonas Ekblom, Ph.D.
Jun Wu, Ph.D.
Jeff Koehler, Ph.D.
Elizabeth Rietz
|
|
Optimization of Electroporation Parameters
Natascha Weiss
Wolfgang Bielke, Ph.D.
Peter Hahn, Ph.D.
|
|
Planning and Designing Biopharma Plants
Karin Koller
|
|
Industry on Target for a Successful Year
G.Steven Burrill
|
|
| November 15, 2007 (Vol. 27, No. 20) |
|
Invitrogen Taps Into Cell Biology Expertise
Carol Potera
|
|
BioMarket Trends: Application of RFID Can Save Time and Money
Bruce Carlson
|
|
Letter to the Editor: What About Tysabri as an MS Treatment?
|
|
Eurofins MWG Consolidates Companies' Offerings
Sophia Fox
|
|
Improved Screening for Better Lead Generation
Lloyd Dunlap
|
|
Getting a Handle on Signal Transduction
Kathy Liszewski
|
|
Seeking the Big Picture with Microarrays
Gail Dutton
|
|
Innovations in Membrane Filtration Tools
Angelo DePalma, Ph.D.
|
|
Advancing Cancer Vaccines
Sue Pearson, Ph.D.
|
|
Army Hospital Reborn as Bioscience Park
Carol Potera
|
|
Sizing Up Genzyme's Takeover Potential
|
|
Subsidizing Biofuels Is Not the Answer
William K. Jaeger, Ph.D.
|
|
Characterizing Stable Protein Formulations
Sigrid Kuebler
|
|
TF Profiling in Drug Discovery
Fiona Coats, Ph.D.
James Lazar, Ph.D.
Sherry Challberg, Ph.D.
|
|
ApplicationNote: Dendritic Cell-Based Immunotherapeutics
Fred Miesowicz, Ph.D.
|
|
Enhancing Performance in Cell Culture
James Babcock, Ph.D.
Shawn Smith
Hans Huttinga
Debra Merrill
|
|
| November 1, 2007 (Vol. 27, No. 19) |
|
Millipore's Acquisitions Enhance Offerings
Carol Potera
|
|
BioMarket Trends: Liquid Chromatography Market Proliferates
Shankar Sellappan, Ph.D.
|
|
Leveraging Impact of Biodefense Contracts
Gail Dutton
|
|
Fragment-Based Discovery in Spotlight
Elizabeth Lipp
|
|
Pushing Toward a $1,000 Genome
Vicki Glaser
|
|
Use of LC Grows in MS Sample Prep
K. John Morrow Jr., Ph.D.
|
|
Weighing In On Genetic Testing & Research
Joan Zimmerman
|
|
Boosting Use of Microbial Systems in Manufacturing
Sue Pearson, Ph.D.
|
|
New Approaches Push Antibodies Ahead
Nina Flanagan
|
|
Defining Bench to Bedside Success
Lynn Sutherland
|
|
Tough Road for Biotech Patent Prosecution
Fangli Chen, Ph.D., J.D.
Brian A. Fairchild, Ph.D.
|
|
POINT OF VIEW: Genetically Modified Foods Unsafe? Evidence that Links GM Foods to Allergic Responses Mounts
Jeffrey M. Smith
|
|
ApplicationNote: New Tool Refines Tissue Homogenization
Hong Gao
Stephanie Thompson
Romain Verollet
Antonin Duval
|
|
Removing Entrenched Bottlenecks in HCS
Mark A. Collins, Ph.D.
|
|
Assay: Measurement of Mitochondrial Function
David Ferrick
Steve Chomicz
Min Wu
|
|
Characterizing Culture Process Dynamics
Geoffrey Esteban
|
|
Tackling Financing Challenges in Biotech
Ron Cohen, M.D.
|
|
| October 15, 2007 (Vol. 27, No. 18) |
|
HPLC Column Provider Expands Focus
Carol Potera
|
|
Application of Real-Time qPCR Broadens
Vicki Glaser
|
|
Disease Pathway Analysis
Joan Zimmerman
|
|
Reducing Attrition with Image Analysis
Susan Aldridge, Ph.D.
|
|
Overcoming Size Concerns in Cell Culture
Angelo DePalma, Ph.D.
|
|
Biologics Force Changes in Stability Testing
Gail Dutton
|
|
China Expanding Bioresearch Activities
Vicki Glaser
|
|
ServiceNote: Human Tissue Research for Drug Discovery
Amanda J. Woodrooffe, Ph.D.
Robert A. Coleman, Ph.D.
|
|
BioMarket Trends: Process Improvements Bolster Peptide Drug Market
Ramin Saberi
Anil Sehgal, Ph.D.
|
|
Ventana Says Its Is Worth More Than $3B
Querida Anderson
|
|
Preparedness for Bioterrorism
Rae Lyn Burke, Ph.D.
|
|
Making RNA More Durable at Room Temp
Sharron Ohgi
|
|
Application Note: Continuous Cell Profiling Technology
Elke Thedinga, Ph.D.
Michael Schulze, Ph.D.
|
|
Assay: New Substrates for FRET-Based Assays
Vera Rakhmanova, Ph.D.
Rich Meyer, Ph.D.
Xiaohe Tong
|
|
Microbe Expression Requires Flexibility
Bo Kara
Ian Hodgson
|
|
| October 1, 2007 (Vol. 27, No. 17) |
|
Alpha Biologics Takes Global Approach
Sophia Fox
|
|
Revamping Drug Discovery Strategies
Patricia F. Dimond, Ph.D.
|
|
Cytometry Drives New Business Models
K. John Morrow Jr., Ph.D.
|
|
Personalized Medicine Seeks Mainstream
Elizabeth Lipp
|
|
CMOs Focused on Meeting Needs and Time Lines
William Downey
|
|
Producing Biologics Less Expensively
Sue Pearson, Ph.D.
|
|
Transforming Healthcare With Stem Cells
Susan Aldridge, Ph.D.
|
|
Benefits Point Biotech Firms to Buffalo
Vicki Brower
|
|
Biomarket Trends: Four Therapies Dominate MS Treatment
Melissa Elder
|
|
IP May Be a Tonic for Distressed Companies
Ronald S. Gellert
Gregory J. Urbanchuk
|
|
Risk-Averse Behavior Entrenched at FDA
Henry I. Miller, M.D.
|
|
Automated Target Preparation Solution
Zhu Zhu
Handy Yowanto, Ph.D.
Keith Roby
|
|
Assay: Validating Biomarkers with VeraCode
Mickie Henshall
Elliott Gorfain
|
|
Application Note: High-Throughput Process Development
H.Brett Schreyer
Scott E. Miller
Seth Rodgers
|
|
Use of Perfusion Technology on the Rise
Bruce Jon Compton, Ph.D.
Jacob Peter Jensen
|
|
Ways to Address Neglected Disease Issue
Cecilia Chan
|
|
| September 15, 2007 (Vol. 27, No. 16) |
|
Start-Up Firm Touts Mid-Stage Pipeline
Carol Potera
|
|
Biomarket Trends: Proteomics Sample-Prep Market Is Ripening
Jonathan Witonsky
|
|
Application Note: Strategies for the Culture of CHO-S Cells
Kevin A. Auton, Ph.D.
Julie A. Bick, Ph.D.
Ian M. Taylor, Ph.D.
|
|
The Game Plan for Sigma's Research Biotech
|
|
Expediting Biomarker Advances
Joan Zimmerman
|
|
Ways to Arm Antibodies Under Increasing Scrutiny
K. John Morrow Jr., Ph.D.
|
|
Capitalizing on microRNA Expression
Kathy Liszewski
|
|
Moving Biotechnology Forward with PAT
Susan Aldridge, Ph.D.
|
|
Disposables Reach Out to New Markets
Nina Flanagan
|
|
Flanders Striving to Attract Biotechnology
Querida Anderson
|
|
Pfizer Deal Pulls Xoma Out of August Slump
Querida Anderson
|
|
Too Many Mice, Too Few Pathologists
Robert D. Cardiff, MD, Ph.D.
Bruce W. Altrock, Ph.D.
|
|
New Kit Facilitates Small RNA Cloning
Eric J. Devor, Ph.D.
|
|
Assay: Laser-Scanning Cytometry in Oncology
Paul Wylie, Ph.D.
|
|
Cultivating Anchorage-Dependent Cells
Jose Castillo
Steven Vanhamel
|
|
| September 1, 2007 (Vol. 27, No. 15) |
|
Corning Targets Screening & Cell Growth
Carol Potera
|
|
Biomarket Trends: Pharmaceutical Industry Undergoing Transformation
Steve Arlington
Anthony Farino
|
|
Operating Costs for Regional Clusters
John H. Boyd
|
|
Malaysian Gov't Fosters Biotech Growth
Robert Yuan, Ph.D.
|
|
Accelerator MS Is a Powerful New Tool
Kate Marusina, Ph.D.
|
|
Advancing Most Promising Compounds
Elizabeth Lipp
|
|
Use and Support of Forensics Flourishes
Gail Dutton
|
|
Transforming Transfection Technology
Patricia F. Dimond, Ph.D.
|
|
Process Analytics Remains Elusive Goal
Angelo DePalma, Ph.D.
|
|
Techniques to Ramp Up Protein Purification
Vicki Glaser
|
|
Stem Cell Firms Struggle for Financing
Gail Dutton
|
|
Molecular Imaging in Drug Development
Amit Agarwal
|
|
Biopharmaceutical IP Protection in China
Susan B. Fentress
|
|
Is Biomass the New Texas Tea?
Peter C. Lauro
|
|
Amplification of RNA from FFPE Tissues
Paul Siebert, Ph.D.
|
|
Ligand Enrichment and Profiling Method
Lyle Rice, Ph.D.
Debra Cen, Ph.D.
|
|
Combating Mycoplasmal Contamination
Claire Scholfield, Ph.D.
Anne Cox, Ph.D.
Anthony Pitt, Ph.D.
|
|
VC Funding Trends for Life Science Firms
Robert Dellenbach
|
|
| August 1, 2007 (Vol. 27, No. 14) |
|
Thermo Fisher Targets Lab Solutions
Carol Potera
|
|
Biomarket Trends: Pain Therapeutics Sector Ripe with Potential
Ken Rubenstein, Ph.D.
|
|
Company Update: Engineering Solutions for Drug Discovery
Susan Aldridge, Ph.D.
|
|
Application Note: Internalization and Protein Relocation
Andreas Brecht, Ph.D
Olivier Roumanie, Ph.D.
Kathrin Muntener, Ph.D.
|
|
Using AMDE Data to Cut Drug Toxicology Failures
Gail Dutton
|
|
Cell-Based Research Gains Momentum
Elizabeth Lipp
|
|
Effective Optimization: Fight or Flight?
Lloyd Dunlap
|
|
Biomarkers Transform R&D
Kate Marusina, Ph.D.
|
|
Improving Protein Production Processes
K. John Morrow Jr., Ph.D.
|
|
Nurturing Growth of mAb Therapeutics
Catherine Shaffer
|
|
Demand Strong for Upstream Systems
Vicki Glaser
|
|
Strategies for Ensuring Optimal Scale-up
Angelo DePalma, Ph.D.
|
|
Trends in Mass Spec: Understanding a Drug's Metabolic Profile
K. John Morrow Jr., Ph.D.
|
|
Trends in Mass Spec: Roundtable Discussion on MS Analysis
|
|
Quest Continues for Innovations in HPLC
Susan Aldridge, Ph.D.
|
|
USPTO Rejects WARF's ESC Patents
Lisa A. Haile, J.D., Ph.D.
Stacy Taylor
|
|
War on Cancer Is Being Oversold
Ralph W. Moss, Ph.D.
|
|
Debunking Downstream Bottleneck Myth
Gunter Jagschies, Ph.D.
Ann O'Hara
|
|
Animal Models for Clinical Advancement
Colleen Jonsson, Ph.D.
|
|
Assay Tutorial: Engineering Lab-Friendly Lipid Assays
Paul Neilsen, Ph.D.
Colin Ferguson, Ph.D.
James Thompson
Angie M. Branch
Andy Miller
|
|
Biotech Investing a Marathon Not a Sprint
Rod Raynovich
|
|
| July 1, 2007 (Vol. 27, No. 13) |
|
Goodwin Biotechnology Expands to India
Carol Potera
|
|
Biomarket Trends: A Myriad of Approaches Fosters Growth in Early Tox Testing
Steven Heffner
|
|
Screening Technologies & Enabling Instrumentation
K. John Morrow Jr., Ph.D.
|
|
Magnetic Beads for Biomarker Discovery
Nina Flanagan
|
|
Whole Genome Amplification Strategies
Elizabeth Lipp
|
|
Increasing Capacity for GMP Peptides
Vicki Glaser
|
|
Designing Better Purification Schemes
Angelo DePalma, Ph.D.
|
|
CROs Cut Costs for Biotechs
Kathy Liszewski
|
|
Transforming Information into Knowledge
Gail Dutton
|
|
Technote: Addressing Trace Protein Detection
David Hammond, Ph.D.
|
|
KSR: A Bump in the Road for Biotech?
Courtenay C. Brinckerhoff
|
|
Biotech Business Model Thrives
J. Leslie Glick, Ph.D.
|
|
Disposable Mixing System Applications
Annemarie Braun
George Oulundsen
|
|
Parallel Glycoprotein N-glycan Analysis
Nico Callewaert, Ph.D.
Steven Geysens, Ph.D.
Wouter Laroy, Ph.D.
|
|
Multiplexed Gene-Expression Assays
William Radany, Ph.D.
|
|
Assay: Achieving High-Throughput Mass Spec
Can C. Ozbal, Ph.D.
|
|
Assessing the Life Sciences Tool Market
Arshad Ahmed
|
|
| June 15, 2007 (Vol. 27, No. 12) |
|
Nereus Prospects Oceans for Cancer Drugs
Carol Potera
|
|
Opening the Gates on Ion Channel Drugs
Kathy Liszewski
|
|
Reducing Attrition in Late-Stage Development
Susan Aldridge, Ph.D.
|
|
Multiplexing Methods Head to Clinic
Kate Marusina, Ph.D.
|
|
Improving Drugs with Protein Engineering
Trevor Stokes
|
|
Managing Cell-Line Optimization Process
Gail Dutton
|
|
Achieving Better Isolation of Nucleic Acids
Lloyd Dunlap
|
|
China Cultivates Its Healthcare Industry
Robert Yuan, Ph.D.
|
|
BioMarket Trends: Genomics & Impending Market Revolutions
Jonathan Witonsky
|
|
OSI Pharma Needs to Expand Pipeline
Querida Anderson
|
|
Genetic Diagnosis and Wrongful Life
Kevin Costello
|
|
Array Tape for Miniaturized Genotyping
Elaine May, MD
|
|
Magnetic Bead-Based Sample Preparation
Arja Lamberg, Ph.D.
|
|
Identification of High-Producing Clones
Michael Wathen, Ph.D.
Bradley Dalton
Mark Gerber, Ph.D.
Kevin J. Kayser, Ph.D.
James S. Ross
Matthew V. Caple
|
|
| June 1, 2007 (Vol. 27, No. 11) |
|
Lentiviral Vector Assists Gene Therapy
Carol Potera
|
|
Biomanufacturing in Limelight
Susan Aldridge, Ph.D.
|
|
DNA Chips Provide Key to Human Genome Analysis
Nina Flanagan
|
|
Cellulosic Biofuels Abound with Promise
Gail Dutton
|
|
Advances in Structure-Based Drug Design
Elizabeth Lipp
|
|
miRNA Becoming a Research Priority
Catherine Shaffer
|
|
SPR Expands the Knowledge of Proteins
Gail Dutton
|
|
Streamlining HPLC in Bioproduction
Angelo DePalma, Ph.D.
|
|
BIO 2007 Challenges Attendees to Innovate
Ilene Schneider
|
|
Long-Term Time-Lapse Studies Focus on Cells
|
|
BioMarket Trends: Diabetes Market Opportunities Soaring
Steven Heffner
|
|
Company Update: Ludesi Proffers Software and Services
Sophia Fox
|
|
Offshoring Your Intellectual Property
Bart Bassett
Sergio Garcia
|
|
Follow-On Biologics Policy Needs Science
Henry I. Miller, M.D.
|
|
Mass Spectrometry for Metabolomics
Steve Fischer
|
|
Assay: 3-D Cell Colony Assays for HTS Studies
Steven C. Miller, Ph.D.
Evan F. Cromwell
|
|
Biopharmaceutical Purification Strategies
Pranavan Thillaivinayagalingam
Eli Keshavarz-Moore
|
|
Biopharma Sector Leadership in Transition
Benjamin J. Conway
|
|
| May 15, 2007 (Vol. 27, No. 10) |
|
CVBT Banks on Fibroblast Growth Factor
Carol Potera
|
|
Kinase Assays' Therapeutic Potential
Lloyd Dunlap
|
|
Development of Peptide Drugs Advances Briskly
Gail Dutton
|
|
miRNA's Role Rises in Drug Research
Kathy Liszewski
|
|
Mass Spec Protein Analysis Strategies
K. John Morrow Jr., Ph.D.
|
|
Improving Yields in Oligo Manufacturing
Vicki Glaser
|
|
Probing the Biology of Cancer Stem Cells
John F. Wong, Ph.D.
|
|
Pharmacovigilance Impacts Drug Safety
Mike Mentasana
|
|
BioMarket Trends: The Future of Genome Synthesis and Design
Rob Carlson, Ph.D.
Jim Newcomb
Steven Aldrich
|
|
Sangamo Poised to Earn Steady Revenues
Querida Anderson
|
|
Drug Delivery Fuels Specialty Pharma
Felix Theeuwes
|
|
Toxicogenomics for Compound Selection
Megan Laurance, Ph.D.
Brigitte Ganter, Ph.D.
|
|
Assay: Cytotoxic Cell Effector Function Studies
Lisa B. English, Ph.D.
Katherine Gillis
Dianne Fishwild
|
|
Affinity Tagging for Protein Purification
Lee Olech
|
|
| May 1, 2007 (Vol. 27, No. 9) |
|
Improving Pharma Process Operations
Sophia Fox
|
|
Company Update: Blue Gene Tackles Disease and Migration
Carol Potera
|
|
Biomarket Trends: Cell Culture Landscape Changes Rapidly
Steven Heffner
|
|
China Looks to Accelerate Globalization
Robert Yuan, Ph.D.
|
|
So, You Want to Be a Millionaire?
Gail Dutton
|
|
Navigating Complex Pathways in Cancer
Elizabeth Lipp
|
|
Building Better Pipelines with ADME-Tox
Vicki Glaser
|
|
Molecular Diagnostics Revamps Drug Development
Kate Marusina, Ph.D.
|
|
Protein Characterization Entering New Era
Nina Flanagan
|
|
Optimized Facility Design and Utilization
Angelo DePalma, Ph.D.
|
|
BioSimilars Market Ripe for Expansion
Sue Pearson, Ph.D.
|
|
Gene Patents Jeopardize Genetic Testing
Roger Klein, MD, JD
|
|
Curing Cancer: Running on Vapor
Mike Mentasana
Phillip J. Baird, M.D., Ph.D.
|
|
Assay Tutorial: Side-Effect Database for Reducing Toxicity
Ming Liu, Ph.D.
Hao Chen, Ph.D.
|
|
Precision Nanoliter Aqueous Transfer
Jean Shieh
Siobhan Pickett
Joseph Olechno
|
|
HCDF as a Protein Labeling Methodology
Sebastian Fiedler
Christof Knocke
Jennefer Vogt
Harmut Oschkinat
Anne Diehl
|
|
| April 15, 2007 (Vol. 27, No. 8) |
|
SynCo Bio Partners Is Poised for Expansion
Carol Potera
|
|
Biomarket Trends: Shape of RNAi Screening Is Changing Rapidly
Jonathan Witonsky
|
|
Company Update: Banking on Human Embryonic Stem Cells
|
|
Folding@home Adopts PlayStation 3
|
|
Companies Step Up to GPCR Challenge
Susan Aldridge, Ph.D.
|
|
Entering the Promising World of Metabolomics
Gail Dutton
|
|
Harnessing RNAi's Gene-Silencing Power
Kathy Liszewski
|
|
Techniques for Characterizing Biologics
Aicha Otmani, Ph.D.
Fenton Fong
|
|
Enterprising Polymer Delivery Methods
Vicki Brower
|
|
Pharmaceutical Operations Expand in China
Robert Yuan, Ph.D.
|
|
Biosimilars Jumpstart Biotech in India
Nalini Motwani, Ph.D.
|
|
Moving Immunology Research Forward
Alan Koop
|
|
Acadias CNS Pipeline Propels Growth
Querida Anderson
|
|
Searching for Viable Biobusiness Models
Gary P. Pisano, Ph.D.
|
|
Nuclear Imaging Drug Development Tools
Lynn Buchanan, Ph.D.
Paul Jurek, Ph.D.
Russ Redshaw
|
|
Assay: Miniaturizing GPCR-Signaling Studies
Sarah Schultz
Tracy Worzella
|
|
Large-Scale Affinity Chromatography
Frank Detmers
Pim Hermans
Mark ten Haaft
|
|
| April 1, 2007 (Vol. 27, No. 7) |
|
Acceleron Takes on Bone & Muscle Repair
Carol Potera
|
|
Company Update: GE Cultivates Its Life Sciences Business
Carol Potera
|
|
BioMarket Trends: Promises and Challenges of Pharmacogenetics
Harry Glorikian
|
|
Technote: The State of Microsample Quantitation
David Ash
Philippe Desjardins
|
|
Advances in Epitope Tagging Strategies
K. John Morrow Jr., Ph.D.
|
|
CGH for Detecting Copy Number Variation
Vicki Glaser
|
|
Designing Out Up-& Downstream Mismatches
Angelo DePalma, Ph.D.
|
|
Combating Ocular Disease
Elizabeth Lipp
|
|
Regenerative Medicine Enters Realm of Reality
Nina Flanagan
|
|
Keeping an Eye on Rising Biotech Firms
Kenneth H. Buetow, Ph.D.
|
|
Streamlining Biomarker Validation Activities
Vicki Glaser
|
|
In Defense of Gene Patenting
Geoffrey M. Karny
|
|
Glycoanalysis of Recombinant Proteins
Peter Porschewski, Ph.D.
Thibault Geoui, Ph.D.
|
|
Assay: High-Throughput DNA Methylation
Peter W. Laird, Ph.D.
Marina Bibikova, Ph.D.
Jian-Bing Fan, Ph.D.
|
|
Improving Quality in Cryopreserved Cells
John M. Baust, Ph.D.
Ana Maria Pardo
Todd Upton, Ph.D.
|
|
New Funding Model for Start-Ups
Barbara S. Schilberg
|
|
| March 15, 2007 (Vol. 27, No. 6) |
|
AVI Is Taking Antisense Drugs to the Clinic
Carol Potera
|
|
Biomarket Trends: Proteomics Arrays Offer Wide Applications
Jonathan Witonsky
|
|
Funding Embryonic Stem Cell Research
Sigrid Fry-Revere
|
|
Cell Signaling Pathway Analysis
Patricia F. Dimond, Ph.D.
|
|
Evaluating Data Flow in Systems Biology
Kate Marusina, Ph.D.
|
|
Chemogenomics Reveals New Synergies
Kathy Liszewski
|
|
Protein Microarray Market Scope Broadens
Vicki Glaser
|
|
Designing & Running Multiproduct Facilities
Gail Dutton
|
|
Ten Years After Dolly: Where Are We?
Sophia Fox
|
|
Are Kinase Inhibitors Poised for Success?
Peter Lassota
Mark Roskey
|
|
Labeling Can Restore the Public's Trust
Rebecca Spector
|
|
Assay: Accuracy and Precision with Serial Dilution
Joseph W. Barco
Manuel Gomez
Joseph P. Karbowski
Ian Yates
|
|
Multiplex Analysis of Drug Toxicity Markers
Jane Luo, Ph.D.
Han-Chang Chi
Michael Gary Jackson
Yong Yu
Kahaku Oades
Patrick Pezzoli
Gordon Vansant
Scott Boyer
|
|
Disposable Large-Scale Pressure Sensors
Jim Furey
|
|
| March 1, 2007 (Vol. 27, No. 5) |
|
Nanoxis Focuses on Membrane Proteins
Sophia Fox
|
|
BioMarket Trends: Mass Spec Finds a Niche in Biomarkers
Justin Saeks
|
|
Company Update: Advaxis Explores New Cancer Vaccines
|
|
Automation Technologies Drive Solid-Phase Extraction
Gail Dutton
|
|
Technote: Integrated Data Access, Analysis & Support
Kathleen Mensler
|
|
qPCR Methods Are Continuing to Evolve
Nina Flanagan
|
|
Safety/Toxicity Issues in Drug Discovery
Elizabeth Lipp
|
|
Application Note: Column-Free Solutions For Purification
Bruce W. Jarvis, Ph.D.
Haiyang Gruenwald, Ph.D.
|
|
Novel Methodologies Allow Greater Accessibility to qPCR
Nicholas D. Rose
|
|
Strategic Protein Production
K. John Morrow Jr., Ph.D.
|
|
Formulation: One Ingredient for Success
Angelo DePalma, Ph.D.
|
|
China Pharma Basking In Its Spotlight
Eliza Yibing Zhou
|
|
Biotech Has Larger Role in Providing Clean Energy
Susan Aldridge, Ph.D.
|
|
Supplement Article: RT-PCR Enters the Realm of Stochastic Gene Expression
|
|
Licensees May Be Gaining a New Legal Weapon
Richard B. Smith
|
|
Labeling Cloned Food Is Unnecessary
Henry I. Miller, M.D.
|
|
Quantifying Changes in Cellular Energetics
David Ferrick, Ph.D.
Andy Neilson
Min Wu, Ph.D.
Steve Chomicz
|
|
Assay: Optimizing RT-PCR for Pathogen Detection
Steve Harrison
Graham Lidgard, Ph.D.
|
|
Host Strain Development for Proteins
Diane M. Retallack
Charles H. Squires
|
|
Late-Stage Cancer Vaccines Set to Launch
|
|
| February 15, 2007 (Vol. 27, No. 4) |
|
Bioengineering Bacteria for Drug Delivery
Carol Potera
|
|
BioMarket Trends: Diagnostic Tools Change Cancer Treatment
Harry Glorikian
|
|
Role Grows for HPLC in Discovery
Kathy Liszewski
|
|
Label-Free Biosensors Show Early Promise
K. John Morrow Jr., Ph.D.
|
|
New Methods Get SNPs Closer to Clinic
Trevor Stokes
|
|
Regulation Shifts from Product to Process
Vicki Glaser
|
|
Optimizing Antibody Biomanufacture
K. John Morrow Jr., Ph.D.
|
|
Techniques for Cell Culture Improvement
Susan Aldridge, Ph.D.
|
|
Embryonic Stem Cells: Not Just From Humans
Sue Pearson, Ph.D.
|
|
Stem Cells for Discovery & Development
Susan Aldridge, Ph.D.
|
|
Laboratory Asset Management Is Thriving
Gail Dutton
|
|
Dr. Reddy's Revenues Hit the $1B Milestone
Querida Anderson
|
|
Building a Bioscience Cluster
Bill Fair
|
|
Monolithic Columns for Biomolecule Analysis
Srinivasa Rao, Ph.D.
Nathan Bach, Ph.D.
|
|
Assay: Perfect Match Versus Single-Base Mismatch
Ramin Saberi
|
|
Base-Tolerant Affinity Resin for Mabs
Aman Mottaqui-Tabar
|
|
| February 1, 2007 (Vol. 27, No. 3) |
|
Aldagen Isolates Highly Active Stem Cells
Carol Potera
|
|
Biomarket Trends: Diversity Drives Use of siRNA
Tamara Zemlo, Ph.D.
|
|
Techniques to Overcome HTS Bottlenecks
Joan Zimmerman
|
|
$1,000 Genome Remains the Holiest
Kate Marusina, Ph.D.
|
|
RNAi Approaches for Target Validation
Patricia F. Dimond, Ph.D.
|
|
Disposables Win Downstream
Angelo DePalma, Ph.D.
|
|
Improving Protein Production Strategies
K. John Morrow Jr., Ph.D.
|
|
U.K. Working to Optimize Bioproduction
Susan Aldridge, Ph.D.
|
|
Diagnosis, Prognosis, and Therapy Selection
Elizabeth Lipp
|
|
Molecular Diagnostics Market Assessment
Alfred R. Doig
|
|
Puerto Rico Views Itself as a Bio Island
Carol Potera
|
|
Outsourcing Phase IV Pharma Research
|
|
GEN's Annual Wall Street Roundup
|
|
Rosalind Franklin Society Founding Board to Hold First Meeting
|
|
National Security and Scientific Research
Stephen M. Goodman
|
|
Automated Molecular Diagnostics
David H. Persing, MD, Ph.D.
|
|
Assay: High-Resolution Melting & Unlabeled Probes
Deepika deSilva
Jana Blackett
|
|
Genome Analysis: Microsatellites or SNPs
Michele A. Gilson, Ph.D.
Anatoli Tassis, Ph.D.
|
|
Linking Stainless and Single-Use System
John Boehm
|
|
| January 15, 2007 (Vol. 27, No. 2) |
|
Cell Therapeutics Counts on Drug Delivery
Carol Potera
|
|
BioMarket Trends: Cancer Vaccines Exhibit Potential
Bruce Carlson
|
|
Business Savvy for UK Biotechs
Susan Aldridge, Ph.D.
|
|
Making Sense of HCS Information
Lakshmi Kamath, Ph.D.
|
|
Robotic Solutions for Improved Lab Analysis
Ilene Schneider
|
|
RNAi-Based Gene Expression Manipulation
Trevor Stokes
|
|
Laser-Capture Microdissection Advances
Kathy Liszewski
|
|
Omics Prove Handy in Production Processes
Angelo DePalma, Ph.D.
|
|
Uniting Efforts in Molecular Medicine
Kenneth H. Buetow, Ph.D.
|
|
Avastin Pads Genentech's Bottom Line
Querida Anderson
|
|
Funding Challenges for Gene Therapy
Riku Rautsola, Ph.D.
|
|
Human Genome-Wide Association Studies
Tim Keith, Ph.D.
|
|
shRNAs Targeting Tumor Suppressor Genes
Diana Ji
Stacy L. Deeds
Edward J. Weinstein, Ph.D.
|
|
Managing Scale-Up of Recombinant Proteins
Ashley Wigley
Diane Wilkinson, Ph.D.
Dave Mead, Ph.D.
|
|
| January 1, 2007 (Vol. 27, No. 1) |
|
High-Resolution Oligo-Based CGH
Anniek De Witte
Christopher Rizzo
Francisco Cifuentes
|
|
SAFC Biosciences Expands Production
Carol Potera
|
|
BioMarket Trends: DNA Sequencing
Jonathan Witonsky
|
|
Reconstructing the Drug Discovery Pipeline
Elizabeth Lipp
|
|
Changing Game Plan for Protein Profiling
Nina Flanagan
|
|
Industrial Biotech Meets Systems Biology
Jose Manuel Otero
Lisbeth Olsson, Ph.D.
Jens Nielsen, Ph.D.
|
|
Serum for Cell Culture Out, Stem Cells In
Vicki Glaser
|
|
Offshoring R&D Activity
Vicki Glaser
|
|
What the New Congress Spells for Biotech
Gail Dutton
|
|
Therapeutic Cancer Vaccine Options
Sue Pearson, Ph.D.
|
|
The Basics of Patent Licensing Explained
Larry A. Roberts
|
|
Better Science Means Safer Food
Henry I. Miller, M.D.
|
|
Going Beyond Information Retrieval
Darryl Leon, Ph.D.
|
|
Novel Bioreactors for Fragile Glycoproteins
Silke Langhammer
Rene Brecht, Ph.D.
Uwe Marx, Ph.D.
|
|
Biotech's Changing Competitive Landscape
Viren Mehta, Pharm.D.
|
|
| December 1, 2006 (Vol. 26, No. 21) |
|
Bioanalytical Systems Targets CRO Niche
|
|
Finding and Working with a Staffing Firm
|
|
Lab Notebooks Offer Efficiency Gains
Gail Dutton
|
|
Honing in on signal Transduction Pathways
|
|
Gauging Nanobiotech's Promise Realistically
|
|
Research Drives Microscopy Innovations
Elizabeth Lipp
|
|
Collaborative Spirit Fosters Bioinformatics
|
|
Minimizing Cost and Use of Purified Water
|
|
Isolator Technologies Slowly Catching On
Angelo DePalma, Ph.D.
|
|
Marine Bioprospecting for Novel Drugs
Susan Aldridge, Ph.D.
|
|
BioMarket Trends
|
|
Abbreviated Approval of Generic Biologics
|
|
Market Research Tips for Suppliers
|
|
TechNote: Parallel Affinity-Based Sample Preparation
Matilda Almstedt
Jesper Hedberg, Ph.D.
Johan Ohman
|
|
Finding Modulators of the Hh Pathway
|
|
Systems Biology Tools Get Personal
|
|
Basic Considerations for Laboratory Water
|
|
Recent Growth Sets Stage for Q4 2006
|
|
| November 15, 2006 (Vol. 26, No. 20) |
|
Optimizing the Value of Potential Novel Drugs
|
|
Sample Prep Gaining Priority in Discovery
Nina Flanagan
|
|
The Next Generation of DNA Sequencing
Kate Marusina, Ph.D.
|
|
Filtration Technology Steps Up to Next Level
|
|
Product Technologies for Lyophilization
|
|
China-Grown Pharma Products
|
|
BioTime Bets on Blood Replacement
Gail Dutton
|
|
TechNote: High-Throughput DNA Extraction Solutions
|
|
Who Will Lead the Revolution?
|
|
Consistency from a Small Integrated System
|
|
Biospecimen Collection and Management
|
|
Genomic-Proteomic Cell Culture Approaches
|
|
| November 1, 2006 (Vol. 26, No. 19) |
|
GenoLogics Automates Omics for Labs
|
|
Can Pharma & Biotech Foil Counterfeiting?
Gail Dutton
|
|
Outsourcing Can Add Capacity & Expertise
|
|
Multidisciplinary Approach to RNAi
|
|
Antibody Engineering Methods Advance
|
|
Novel Vaccines Expand Potential Markets
|
|
Small Molecule Drugs
|
|
BioMarket Trends
|
|
Maximizing the Value of Biotech Patents
|
|
Biotech Production Is Blooming in the Tropics
|
|
Multiparametric Assays on Individual Cells
|
|
RNAi Libraries for Functional Genomics
|
|
Navigating the Postpreservation Viability Fog
|
|
Third Quarter Life Science Sector Review
|
|
| October 15, 2006 (Vol. 26, No. 18) |
|
BioMarket Trends
|
|
Company Update: Sequencing Technology Applications Expand
|
|
Maximizing Discovery Using Kinase
|
|
Microarrays Find their Way into the Clinic
|
|
Microrarray Standards Are the Next Step
Elizabeth Lipp
|
|
Safety Biomarkers Holy Grail of Toxicology
Kate Marusina, Ph.D.
|
|
Get Quality and Quantity in Your Process
Angelo DePalma, Ph.D.
|
|
Telemedicine Enables Better Care
|
|
Flexible Protein Microarray Inkjet Printing
|
|
Streamlining HTS for Challenging Targets
|
|
Rotating Bioreactors for Manufacturing
|
|
| October 1, 2006 (Vol. 26, No. 17) |
|
New Gene Sequencer Targets Productivity
|
|
BioMarket Trends
|
|
Inflammation Research Leads to Targets
|
|
Expanding Applications of Diagnostic Tools
|
|
Changing the Way Research Is Conducted
|
|
PCR Applications Continue to Expand
Elizabeth Lipp
|
|
New Software Tackles Mounds of Data
|
|
Bringing Pharmacogenomics into the Clinic
|
|
CMOs Aim to Boost Production Efficiency
|
|
Monoliths Seen to Revitalize Bioseparations
|
|
Connecting Basic Research and Patient Care
Susan Aldridge, Ph.D.
|
|
TechNote: Ratiometric Photometry for Calibration
|
|
Patent Rights in Biological Material
|
|
Making the Complex Simple
|
|
Isothermal Titration to Characterize Binding
|
|
Epitope Mapping and Vaccine Research
|
|
Ensuring Efficient Aeration of Cell Cultures
|
|
Life Sciences Strategic Deal-Making Trends
|
|
| September 15, 2006 (Vol. 26, No. 16) |
|
ExSAR Focuses on Discovery & Optimization
|
|
Company Update: ApoLife Touts Yeast-Based Expression System
|
|
BioMarket Trends: Biosensor Markets Outperform Expectations
|
|
European Biotechs Face a Funding Crisis
|
|
Biomolecular Screening Technologies
|
|
Maximizing Cell-Based Imaging Results
|
|
RNAi in Drug Discovery & Therapeutics
Kathy Liszewski
|
|
Bioprocess Simulations Gain Traction
Gail Dutton
|
|
Systematic Approach to Optimizing HPLC
Gail Dutton
|
|
Slow Adoption of PAT for Bioprocessing
|
|
Driving Standards in Single-Use Disposables
|
|
Preclinical R&D Investment Is Crucial to Long-Term Success
|
|
LOH and DNA Copy Number Changes
|
|
Overview of SmartFlow Tangential Flow Filtration
|
|
Minimizing Off-Target Effects in Transfection
|
|
| September 1, 2006 (Vol. 26, No. 15) |
|
ChemDiv's Collaborative CRO Relationships
|
|
Current New Drug Application Requirements
|
|
BioMarket Trends
|
|
VisualSonics Targets the Preclinical Area
|
|
Fluidics for qPCR, Diagnostics & Biodefense
|
|
Protein Crystallization in Pharma Research
Elizabeth Lipp
|
|
Diagnostics in Gene and Protein Expression
|
|
Reconfiguring Mass Spec Instrumentation
|
|
Myriad Options for Molecular Diagnostics
Gail Dutton
|
|
Post-Translational Modification Approaches
|
|
ISPE's Role in Pharma Industry's Transition
|
|
Process Monitoring On-Line & in Real-Time
Angelo DePalma, Ph.D.
|
|
Chinese Biogenerics and Protection of IP
|
|
Bringing Drugs and Devices Together
Susan Aldridge, Ph.D.
|
|
The Bioethics of IVD Devices and Informed Consent Issues
|
|
Automation of Protein Crystallography
|
|
Physiologically Relevant HTS Technologies
|
|
IntegratedProcess Design & Development
|
|
Novel Diagnostics Help Target Therapies
|
|
| August 1, 2006 (Vol. 26, No. 14) |
|
TechNote: Ca2+ Signal Detection in HTS Operations
|
|
Biomarker Discovery and Identification
|
|
Whither Steel & Glass in a Disposable Age
|
|
TechNote: Antibiotic-Free Systems for Production
|
|
Case Study: Vaccine Production Facility Built in 11 Months
|
|
Biopharmaceutical Approvals Review
|
|
GEN Innovations in Biotechnology
|
|
Company Update: Biofocus Expands its Menu of Offerings
Sophia Fox
|
|
Role of Cell-Based Assays in R&D Grows
Elizabeth Lipp
|
|
Drug Discovery: Successful Lead Optimization Strategies
Kathy Liszewski
|
|
Multidimensional Analysis Approaches
Gail Dutton
|
|
Overcoming the Critical Issues in Scale-Up
Susan Aldridge, Ph.D.
|
|
Development & Production of Antibodies
|
|
BioMarket Trends
|
|
Facilitating the Manufacturing of Oligos
Carol Potera
|
|
Monoclonal Antibody Purification with CHT
|
|
Versatile Tag for Cell-Based Screening
|
|
Novel Technique for Biomarker Discovery
|
|
German Biotechs Embrace Reverse Mergers
|
|
| July 1, 2006 (Vol. 26, No. 13) |
|
Using Biotech Tools for Plant Breeding
|
|
BioMarket Trends
|
|
Targeting Biotech Institutional Investors
|
|
Epitope Tagging Generates New Products
|
|
Protein Kinases in Signal Transduction
|
|
Range of Applications for Biomagnetics
Gail Dutton
|
|
Market Growing for Custom-Made Peptides
|
|
Antiviral Research Hits Its Stride
Elizabeth Lipp
|
|
CROs Become a Biotech Industry Staple
Susan Aldridge, Ph.D.
|
|
Spotlighting Neurobiotech Developments
|
|
Combating the R&D Productivity Decline
|
|
Disclosure Issues for Life Sciences Firms
|
|
Metrics for Economic Development
|
|
Getting More Value from Bioinformatics
|
|
Barcoding and Automated Electophoresis
|
|
New Tools Improve Bioprocess Operations
|
|
Pre-Deal Leadership Due Diligence a Must
|
|
| June 15, 2006 (Vol. 26, No. 12) |
|
Pain Therapeutics Takes Different Path
|
|
Biomarket Trends
|
|
Nucleic Acid-Based Technologies Ramp Up
|
|
Going a Label-Free Route with Biosensors
|
|
Enabling Technologies at MipTec 2006
Susan Aldridge, Ph.D.
|
|
Focus on Mid-Densities Drives Multiplex Arrays
Gail Dutton
|
|
Biomanufacturing for Regenerative Medicine
Kathy Liszewski
|
|
Disposable Bioreactors Gaining Favor
|
|
Progress Report on the NIH Roadmap Initiative
|
|
Scientific Interactions Advancing in Mid-East
|
|
Gilead Targets HIV & Bird Flu Markets
Querida Anderson
|
|
ID and Validation of Biomarkers
|
|
Cell Density and Physiology Monitoring
|
|
Assay: Parallel Approaches to Target Identification
|
|
Proteome Partitioning and Fractionation
|
|
| June 1, 2006 (Vol. 26, No. 11) |
|
Thermogenesis' Art of Cryopreservation
Kate Marusina, Ph.D.
|
|
GEN's Annual Top 20 Molecular Millionaires
|
|
Governor Says Puerto Rico Will Not Rest on Pharmaceutical Manufacturing Laurels
|
|
Chromatography Advances Drug Discovery
|
|
Trends & Expectations in Bioinformatics
|
|
Target Screening Focuses on Ion Channels
Elizabeth Lipp
|
|
SNP Genotyping Methods Surge Ahead
|
|
Maintaining Biocontamination Control
Angelo DePalma, Ph.D.
|
|
Pharmaceutical Tech Transfer in the Spotlight
Susan Aldridge, Ph.D.
|
|
Biofirms Develop Novel Therapeutics for MS
|
|
When is Private Really Public?
|
|
Marijuana, Medicine & the FDA
|
|
Protein Tomography Applications Expand
|
|
Assay Tutorial: Adenoviral Vector Gene Delivery System
|
|
Microbial and Cell Growth in Microtiter Plates
|
|
Reverse Mergers in Life Science Financing
|
|
| May 15, 2006 (Vol. 26, No. 10) |
|
eGene Transforms Genetic Analysis Field
|
|
Deviation Controls in Pharmaceutical R&D
|
|
Sample Prep Upstream of Mass Spectrometry
Vicki Glaser
|
|
Inhibiting Protein-Protein Interactions
|
|
Nonviral Approaches to DNA Delivery
Kathy Liszewski
|
|
Targeting a Multibillion-Dollar Market
Querida Anderson
|
|
Are We Being Outdone by Bacteria?
|
|
Using Isothermal Titration Calorimetry
|
|
Assay: Proteomics Technology for Plasma & Serum
|
|
Glucose Measurement for Cell Culture
|
|
| May 1, 2006 (Vol. 26, No. 9) |
|
Source MDx Advances Molecular Medicine
|
|
Former President Says Biotech Must Address Energy Needs
|
|
Advice on How to Survive the Taq Wars
|
|
ADMETox Improves Drug Discovery Rates
|
|
Systems-Based Approach Gaining Ground
Angelo DePalma, Ph.D.
|
|
Fragment-Based Drug Design Optimizes Hits
|
|
Utilizing Metabolic Profiling in Discovery
|
|
Pittcon 2006 Launches and Highlights
|
|
Surviving the Treacherous Transgenics Path
|
|
Navigating the Bench to Bedside Journey
|
|
Novel Products for Life Sciences Imaging
Susan Aldridge, Ph.D.
|
|
Analysis of a Patent Applicant's Obligations
|
|
Nanotechnology in Global Security and Economics
|
|
Surface Treatments for Fastidious Cells
|
|
Detecting MD-Associated Gene Variants
|
|
New Platform for Producing Viral Vaccines
|
|
Brave New World of Patents and Pricing
|
|
| April 15, 2006 (Vol. 26, No. 8) |
|
Chemo-Proteomics Approach to Cancer
|
|
Access to Global Networks in Life Sciences
|
|
Methods to Develop and Validate Bioassays
Kathy Liszewski
|
|
Peptide Drug Discovery Research Reenergized
|
|
Achieving Seamless RNA Analysis
|
|
Market Increases Oligonucleotide Demands
|
|
Microsoft Establishes the BioIT Alliance
|
|
Isis Moves Ahead on Antisense Program
Querida Anderson
|
|
Bridging Biological Systems Knowledge Gaps
|
|
Assay: Microfluidic Capillary Electrophoresis
|
|
Glycosylation Patterns During Fermentation
|
|
| April 1, 2006 (Vol. 26, No. 7) |
|
Genta Seeks Therapeutic Product Approval
|
|
Asian Biotech: Taiwan Seeks Successful Business Models
Robert Yuan, Ph.D.
|
|
Conference Highlights Drug Delivery Methods
|
|
Life Science Cluster Grows in London
Susan Aldridge, Ph.D.
|
|
Biotechnology's Mid-Caps Post Solid Gain
|
|
Commercial Amounts of Purine Nucleosides
Sophia Fox
|
|
Nanobiotech in Genomics and Proteomics
|
|
Taming the Genome with Microarrays
Elizabeth Lipp
|
|
Protein Characterization Applications Grow
|
|
Next-Generation Protein Characterization
Susan Aldridge, Ph.D.
|
|
Technical Note: Highly Sensitive qRT-PCR from One Cell
|
|
Lean and Six Sigma Approaches Taking Hold
Angelo DePalma, Ph.D.
|
|
Characterization of Biologicals Is Advancing
|
|
Patent Litigation: Is it Worth the Expense?
|
|
Medical Science Liaisons in Biotech
|
|
Assay: Protein Production for Structural Analysis
|
|
Streamlining Pharmacogenetic Analysis
|
|
Thermal Welding for Sterile Connections
|
|
Emerging Biopharmaceutical Companies
|
|
| March 15, 2006 (Vol. 26, No. 6) |
|
The FDA and Follow-On Biologics
|
|
Solutions for Cell-Focused Applications
Sophia Fox
|
|
Benefits of Structure-Based Drug Design
|
|
Assays for Cell Proliferation Studies
|
|
Cheminformatics for Finding New Drugs
Elizabeth Lipp
|
|
Biomarker Detection & Measurement
Kathy Liszewski
|
|
Tissue Microarrays Reach New Markets
|
|
CMOs Find Opportunities in Biologics
|
|
Multiproduct Manufacturing Facilities
|
|
Analyst Likes AEterna Long-Term
Querida Anderson
|
|
Implications of Faith-Based Science
|
|
Assay: Quantitative Multiplex Immunoassays
|
|
Improving Protein Interaction Analysis
|
|
Integrating Chirality into Manufacturing
|
|
| March 1, 2006 (Vol. 26, No. 5) |
|
Finding a Balance in Assessment of Risk
|
|
M&As as Important Development Tools
|
|
Corporate Profile: Beckman Removes Divisional Barriers
|
|
Clearing the Target Validation Bottleneck
|
|
In vivo and In vitro Techniques Help to Unclog the Drug Discovery Process
|
|
LabAutomation 2006 Final Recap
|
|
Protein Arrays as Key Discovery Tools
|
|
HPLC Undergoes Slow, Steady Evolution
Angelo DePalma, Ph.D.
|
|
QA/QC for Viral Clearance
Gail Dutton
|
|
Purification Woes Upstage Upstream Gains
|
|
ELN and LIMS Aid Biotechnology Growth
|
|
Pitfalls in Patenting of Biomolecules
|
|
Good News on Medicines but Bad Rap for Drug Makers
|
|
Achieving Low-Volume Liquid Handling
|
|
Cell-Based Assays for Study of GPCRs
|
|
Choosing & Scaling Up Right Filter Combo
|
|
M&As as Important Development Tools
|
|
| February 15, 2006 (Vol. 26, No. 4) |
|
Tracking Diseases at the Molecular Level
Sophia Fox
|
|
Metabolomics Plays Crucial Discovery Role
Kathy Liszewski
|
|
In Silico Tools Streamline Drug Design
Gail Dutton
|
|
Target Identification Methods Advance
Elizabeth Lipp
|
|
Capitalizing on Biotech Production Opportunities
Susan Aldridge, Ph.D.
|
|
Ready-to-Play Assays, Kits, and Libraries
|
|
Large-Scale Production of Antibodies
|
|
CancerVax' Stock Rises with Merger
|
|
In Support of Animal Study Management Software
|
|
Assay: Miniaturized Cellular Assays
|
|
Next-Generation RNA Interference
|
|
Optimizing Bacterial Cell Processing
|
|
| February 1, 2006 (Vol. 26, No. 3) |
|
Biolog Advances Global Cell Analysis Scans
|
|
Drug Discovery and Development in India
|
|
Extracting Compounds for Diverse Disciplines
|
|
Technical Note: Relieving the HTS Bottleneck for Kinases
|
|
Optimizing High-Throughput Screening
|
|
Improving Gene Expression Analysis
|
|
Bright Sky for Single-Use Bioprocess Products
Angelo DePalma, Ph.D.
|
|
Scientific Misconduct: Risks to Biotechnology
|
|
Wake-up Call for U.S. Innovation
|
|
Planning, Documentation, and Collaboration
|
|
Multiplex Transcription Factor Profiling
|
|
Testing & Validation of Disposable Systems
|
|
| January 15, 2006 (Vol. 26, No. 2) |
|
New York City Pursues Biotechnology Dream
|
|
State of Industry Discussed at BIO-Europe
Susan Aldridge, Ph.D.
|
|
Licensing & Collaborations for Tamiflu Patent
Gail Dutton
|
|
DeveloGen Tackles Metabolic Disorders
Sophia Fox
|
|
Cellular Analysis via High Content Screens
Elizabeth Lipp
|
|
Improving Stability While Adding Value
Angelo DePalma, Ph.D.
|
|
Development of Stem Cell Technologies
|
|
New Biomolecules for Cancer Treatment
|
|
French Biotech on the Upturn
|
|
Corporate Partnering Status Report
|
|
Steps for Preventing the Misuse of Biological Research
|
|
Proteomics-Based Biomarker & Drug Discovery
|
|
Assay: Protein Microarrays on Nitrocellulose Slides
|
|
Embryonic Stem Cell Research Operations
|
|
| January 1, 2006 (Vol. 26, No. 1) |
|
Biopartnering Crucial to Survival in Europe
Susan Aldridge, Ph.D.
|
|
Establishing QC for Molecular Diagnostics
|
|
Measurement of a Communications Program
|
|
New Tools Highlighted at ASHG Conference
|
|
Protein Profiling Poised to Make its Mark
Angelo DePalma, Ph.D.
|
|
Correlating Genomics, Race, and Medicine
Gail Dutton
|
|
French Biotech Hungers for Fiscal Stimuli
|
|
Applying Biomarker Discovery Strategies
|
|
RNAi Technologies Become Discovery Staple
|
|
Toxicogenomics Enhances Drug Discovery
Kathy Liszewski
|
|
Downstream Processing Needs a Boost
Susan Aldridge, Ph.D.
|
|
Cell Culture Advances Enable Better Biology
|
|
BioMarket Trends: Cell Culture Arena Fueled by Emerging Variety of Biologic Therapeutics
|
|
Gene Patents and Global Competition Issues
|
|
Policymakers Should Harness User Fees for Drug Safety
|
|
Effective GPCR Screening Using ERK 1/2
|
|
Maximizing Quality in HTS Kinase Screening
|
|
Taking the Guesswork Out of Production
|
|
| December 1, 2005 (Vol. 25, No. 21) |
|
Mobilizing Nanomedicine Technologies
|
|
Industry Analysis of Discovery Informatics
|
|
Employment Trends in the Biotech Industry
|
|
High Purity Water: Combating Contamination
Gail Dutton
|
|
Protein Microarrays
|
|
Fluoresence & Bioluminescence Enlighten R&D
|
|
Strategies to Move Beyond Target Validation
|
|
Biosimilars Shake up the Biologics Market
|
|
Taiwan Industry Puts Strong Focus on Biotech
|
|
PTO Utility Guidelines Receive Stamp of Approval
|
|
Designing an Effective Preclinical Profiling Strategy
|
|
Simplified Development of FRET Assays
|
|
Using Multi-Pathway Target Knockdown
|
|
Parenteral Packaging Concerns for Drugs
|
|
Biotech Posts Impressive Third Quarter Results
|
|
| November 15, 2005 (Vol. 25, No. 20) |
|
The FDA Inspection Process as a Learning Tool
|
|
Tissue Models Boost Drug Discovery Efforts
|
|
Scotland Pursues Stem Cell Excellence
|
|
Chiral Chemistry Aids Drug Development
Gail Dutton
|
|
Advancing Viral Vector-Based Technology
|
|
Resilience Challenged and in Short Supply in Our Society
|
|
Protein Identification and Quantification
|
|
Platforms for Eicosanoid Measurements
|
|
Optimizing Your Process Unit Operations
|
|
| November 1, 2005 (Vol. 25, No. 19) |
|
Emerging Technologies for Ion Channels
|
|
Challenges Remain for Antibody Products
|
|
A New Spin on Plasma Biomarker Discovery
|
|
Commercial Bioactivities in Western Canada
|
|
Patent Rights and Pharmaceutical Reimportation
|
|
Bridging the Gap between Model Systems and Human Biology
|
|
Electronic Laboratory Notebook Systems
|
|
Purification for Demanding Applications in Life Sciences
|
|
The Shrinking Biomanufacturing Facility
|
|
How to Improve Series B-Round Valuations
|
|
| October 15, 2005 (Vol. 25, No. 18) |
|
Review of FDA Guidance on Risk Management
|
|
Molecular Diagnostics as Clinical Tools
Gail Dutton
|
|
Blue Biotech Puts Norway on the Map
Susan Aldridge, Ph.D.
|
|
Whole Genome Amplification Technologies
Mary Addonizio
|
|
Novel Systems for Visualizing Biological Data
Kathy Liszewski
|
|
Singapore Attracts Life Science Companies
|
|
The State of BSE Surveillance Efforts in the United States
|
|
Optimized Solutions for RNAi Experiments
|
|
Utilizing Rapid Point-of-Use Protein Assays
|
|
Recipe for Ensuring Process Control Success
|
|
GEN's Spotlight on Wall Street News
|
|
| October 1, 2005 (Vol. 25, No. 17) |
|
Contract Manufacturing Fills Industry Niche
|
|
Linking Discovery Data to Diagnostics
Elizabeth Lipp
|
|
GEN Talks with President Bill Clinton
|
|
Biotechnology in Australia and New Zealand
|
|
Nucleic Acid Purification Takes Many Forms
Ilene Schneider
|
|
Manipulation and Analysis of Nucleic Acids
|
|
A Step Forward for Biotechnology Patent Law
|
|
Proposition for a New and Better Model for Healthcare
|
|
Achieving Optimal Yields of High Quality RNA
|
|
How do Bacteria Turn Their Genes On and Off?
|
|
Nanoscale Gradient Chromatography for LC-MS
|
|
Manufacturing of Biopharmaceutical Proteins
|
|
Diabetes: Potential Breakthroughs in Therapy
|
|
| September 15, 2005 (Vol. 25, No. 16) |
|
Applying Mass Spec Tools in Proteomics
|
|
Biomolecular Screening Technologies Advance
|
|
Flanders' Biotech Sector Comes of Age
|
|
Molecular Biology Software Product Update
Kevin Ahern
|
|
Microarrays for Model Organism Systems
|
|
Patent Law in India Focuses Strongly on R&D
|
|
Science and Democracy in Europe and the United States
|
|
Novel Tests Based on Genomic Markers
|
|
Casting a New Light on GPCR Targets
|
|
Lyophilization: Growing with Biotechnology
|
|
GEN's Spotlight on Wall Street News
|
|
| September 1, 2005 (Vol. 25, No. 15) |
|
Preparing for a Potential Pandemic
Gail Dutton
|
|
Funding Issues Slow Establishing Biobanks
|
|
In Silico Modeling Begins to Produce Results
Gail Dutton
|
|
Prion Disease Mechanisms and Activation
|
|
Outsourcing Drug Discovery & Development
|
|
Whole Genome Sequencing in 24 Hours
|
|
Advances in Protein Arrays Overcome Obstacles
Kathy Liszewski
|
|
Minnesota Toots Its Own Life Science Horn
|
|
The Scylla & Charybdis Face Integrated Genomics
|
|
Halting the March of Unreason
|
|
High-Sensitivity Mutation Scanning of Tumors
|
|
Utilizing a New Tool for Drug Discovery
|
|
Enhancing System Cleanliness & Drainability
|
|
Biotech and Pharma in a Turbulent World
|
|
| August 1, 2005 (Vol. 25, No. 14) |
|
Twenty-Five Years of Biotech Trends
Angelo DePalma, Ph.D.
|
|
Bioresearch Highlights Significance of SNPs
|
|
Drug Delivery Technology: Deals and Advances
|
|
Optimizing Strategies for Hit-to-Lead Process
|
|
Twists and Turns on the Path to Find New Drugs
|
|
North Carolina Leads Southeast in Biotech
|
|
Innovative Antibody Products and Therapeutics
|
|
Disposable Bioreactors Become Standard Fare
|
|
Safe Harbor Provisions for Preclinical Research
|
|
Taking a Journey-Based Approach to Manufacturing Development
|
|
Automating True Manual Patch Clamping
|
|
New Tool for Metabolic Disease Research
|
|
Animal-Derived Agents in Disposable Systems
|
|
Asia Offers Opportunities in Pharmaceuticals
|
|
| July 1, 2005 (Vol. 25, No. 13) |
|
Navigating Stem Cell Fact and Fiction
Gail Dutton
|
|
Developing Sophisticated Protein-Based Drugs
|
|
Tapping the Potential of Protein Drug Discovery
|
|
Peptide Manufacturers See Increased Growth
|
|
Biomagnetic Separations Move to Next Level
Gail Dutton
|
|
Authorized Generics: To Switch Rather than Fight
|
|
Evidence-based Medicine
|
|
Optimized Chemical Libraries in Drug Discovery
|
|
Targeted Disruption Using Group II Introns
|
|
High-Yield Single-Use Cell Culture Systems
|
|
| June 15, 2005 (Vol. 25, No. 12) |
|
FDA Needs to Balance Risks and Benefits for Patients
|
|
Applying Nanotech to Materials Research
Gail Dutton
|
|
New Biomanufacturing Opportunities & Challenges
Susan Aldridge, Ph.D.
|
|
PCR Gains Momentum with New Applications
|
|
High Demand for Target Validation Technologies
|
|
Using Complexity to Enhance Drug Discovery
|
|
Research Options for Structural Proteomics
Gail Dutton
|
|
Can India's IT Success be Replicated in Biotech?
|
|
Survey of European Scientists on Ethics of Scientific Advancements
|
|
Taking Computational Biology to the Bench
|
|
Miniaturized Filtration Assay for Discovery
|
|
Evaluation of the CellFerm-Pro STBR System
|
|
| June 1, 2005 (Vol. 25, No. 11) |
|
Optimizing the Drug Target Search
Susan Aldridge, Ph.D.
|
|
Greater Philly Region Grows as a Bio Cluster
|
|
Functional Genomics Reveals Mysteries of Genes
|
|
Ways to Overcome the Small Molecule Curse
|
|
Trends in Incubator and Shaker Technologies
|
|
Oligo Manufacturing Puts Emphasis on RNA
|
|
Mass Spectrometry in the Life Science Market
|
|
Examining NIH Policy to Enhance Public Access
|
|
Applying PAT to Oligonucleotide Synthesis
|
|
Microarray Data Management and Analysis
|
|
Integrated Workflow for Development Testing
|
|
Anti-Cancer Therapy Success
John F. Wong, Ph.D.
|
|
| May 15, 2005 (Vol. 25, No. 10) |
|
Regulation of Combination Products by the FDA
|
|
Medicinal Chemistry Equals New Leads
Susan Aldridge, Ph.D.
|
|
Cutting Through the Biomarker Hype
Elizabeth Lipp
|
|
Moving Toward System-Wide Software Suites
Gail Dutton
|
|
Signal Pathways Making Inroads in Discovery
|
|
Growth of Virginia's Life Science Clusters
|
|
Preparation of Clinical Trials Materials
|
|
| May 1, 2005 (Vol. 25, No. 9) |
|
Making Innovation Work in Drug Discovery
Susan Aldridge, Ph.D.
|
|
Creating and Educating a New Biotech Workforce
|
|
In Vivo Molecular Imaging Poised for Growth
|
|
Biosensors & Biomolecular Interaction Analysis
|
|
Expansion of Proteomic Databases Needed
|
|
Expansion of Proteomic Databases Needed
|
|
Licensing Problems with Diagnostic Genetic Testing
|
|
Opportunities and Challenges for Developing Functional Foods
|
|
Outsourcing and Globalization in the Industry
|
|
| April 15, 2005 (Vol. 25, No. 8) |
|
Submitting Pharmacogenomic Data to the FDA
|
|
Putting the Squeeze on Manufacturing
|
|
Interfering with RNA
|
|
NIH Ethics Regulations
Gail Dutton
|
|
California Stem Cell Institute Starts Slowly
|
|
Microarray Technologies Advancing Medicine
|
|
Sample Management and Storage Systems
|
|
Turbocharging Expression Microarrays
|
|
Establishing a Biotech Industry in Singapore
Robert Yuan, Ph.D.
|
|
Biotechnology in Vancouver
|
|
Some Activist Groups Exibit a
|
|
| April 1, 2005 (Vol. 25, No. 7) |
|
Pharma Struggles with Negative Image
Gail Dutton
|
|
U.S. HUPO Symposium Focuses on Proteomics
|
|
Chemical Genomics Facilitates Finding Targets
Mary Addonizio
|
|
Singapore Grooms Firms for Success
Robert Yuan, Ph.D.
|
|
Trends in Viral Validation
Gail Dutton
|
|
Michigan Life Sciences Industry Extends Roots
|
|
Biotechs Focus on Critical Medical Needs
|
|
Can a Strong Patent Position Be Illegal?
|
|
Reducing Risk with
|
|
| March 15, 2005 (Vol. 25, No. 6) |
|
FDA Final Current Good Tissue Practice Rule
|
|
Screening Technology Challenges
Susan Aldridge, Ph.D.
|
|
Using Nanotechnologies In Biotech and Medicine
|
|
Lab Automation 101: Effective Integration
|
|
The Growing Allure of Rational Drug Design
Kathy Liszewski
|
|
Biotech in Wales Quietly Thriving
Sophia Fox
|
|
Addressing Stability of Biological Drugs
|
|
Misplaced Attacks on the Pharmaceutical Industry
|
|
| March 1, 2005 (Vol. 25, No. 5) |
|
NIH's New Ethics Regulations
Gail Dutton
|
|
Managing Cardiovascular Disease Risk Factors
|
|
Phoenix Seeks to Advance its Biotech Initiative
|
|
Protein-Protein Interactions in Drug Discovery
|
|
The Spotlight Is on Protein-Folding Disorders
|
|
Metabonomics Providing Clues to Discovery
|
|
Race to Cut Whole Genome Sequencing Costs
|
|
Strengthening Pharma and Biotech Patents
|
|
Is Biotech in the Midst of a Fifty-Year Cycle?
|
|
| February 15, 2005 (Vol. 25, No. 4) |
|
FDA's Draft Guidance on Pharmacogenomics
|
|
Manufacturing Biologicals Effectively
|
|
Personalized Arthritis Therapy
|
|
What it Costs fo Operate a Biotech Facility
|
|
Staying Up-to-Date in Biomarker Research
|
|
Is Biotechnology Complacent to PAT Principles?
Gail Dutton
|
|
Conservative Outlook Seen at Investor Forum
|
|
| February 1, 2005 (Vol. 25, No. 3) |
|
Biobanking Emerging as a Key Growth Area
Susan Aldridge, Ph.D.
|
|
Antibody Therapeutics Dominate Meeting
|
|
High Throughput Screening of GPCRs
Kathy Liszewski
|
|
Advances in Microgenomics: Less is More
|
|
Atlanta Bioscience Breaks into the Top Ten
|
|
Re-Engineering the Drug Development Pipeline
Mary Addonizio
|
|
Could London Become a Major Biotech Hub?
|
|
The Impact of Biotech Licensing
|
|
| January 15, 2005 (Vol. 25, No. 2) |
|
Taking a Look at FDA's Critical Path Initiative
|
|
Pharmacogenomic Tests for Breast Cancer
Gail Dutton
|
|
BIO-Europe Conference Gauges Future
Susan Aldridge, Ph.D.
|
|
High Content Screening Management Options
|
|
Microfluidics Technology Goes Mainstream
|
|
Panning for Drug Discovery Gold with New Tools
|
|
Agilent Advances Lab-on-a-Chip Technique
Susan Aldridge, Ph.D.
|
|
Building Momentum in Scandinavian Cluster
|
|
The Human Side of Science
|
|
| January 1, 2005 (Vol. 25, No. 1) |
|
Vioxx and Celebrex Bring Heat to the FDA
Gail Dutton
|
|
U.K. to Push Bioprocessing to Forefront
Susan Aldridge, Ph.D.
|
|
Obtaining High-Quality Protein Crystals
|
|
Druggability: Prime Real Estate of the Genome
|
|
Exploiting Post-Translational Modifications
Kathy Liszewski
|
|
Progress in Vaccine and Gene Therapy Strategies
|
|
Legal Uses of a Patented Invention in the U.S.
|
|
Drug Importation Equals Bad Public and Economic Policy
|
|
Clinical Data at ASH Boon to Wall St. Analysis
|
INTERVIEW:
(BIO) BANKING IN LUXEMBOURG - Interview with Robert Hewitt, Ph.D., CEO, Integrated Biobank of Luxembourg, and European Editor, Biopreservation and Biobanking (published by Mary Ann Liebert, Inc.)
...MORE
News
Subscribe to RSS
Listen
Save
Comment
View All